StansenSG的个人主页 - 老虎社区

StansenSG

StansenSG

个人简介：health is wealth

IP属地：未知

141关注

287粉丝

0主题

0勋章

2021-10-14

Li

LinkedIn to replace networking platform with jobs-only version in China

2021-09-28

Li

Cannabis stocks jumped in Monday morning trading

2021-11-05

$Progenity, Inc.(PROG)$ too many short list

2021-11-03

Li

1 Red-Hot Semiconductor Stock That Just Crushed Earnings

2021-10-30

Li

Wall Street shakes off Amazon, Apple weakness to end modestly higher

2021-10-22

Li

抱歉，原内容已删除

2021-10-06

Li

Why Peloton Stock Is Becoming a Value

2021-12-28

L

Gaming stocks rose in morning trading

2021-12-26

L

2 Top Stocks to Buy for the New Year

2021-11-24

L

Stocks fall as higher yields hit tech names again, retail earnings disappoint

2021-10-10

Li

Is the stock market open on Columbus Day? Yes! But the bond market isn't--Here's why

2021-12-18

L

抱歉，原内容已删除

2021-11-02

Li

Bionano Genomics shares surged more than 10% in morning trading

2021-10-17

Li

抱歉，原内容已删除

2021-09-30

Li

Stocks rise slightly as Wall Street tries to end losing month on a high note

2021-12-23

L

If I Could Only Buy 1 Stock Right Now, This Would Be It

2021-12-16

L

Bad Omen For Tesla? Here's What Happened To Amazon Stock After Jeff Bezos Was Time's 'Person Of The Year'

2021-11-13

Li

Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3578711428062414,"uuid":"3578711428062414","gmtCreate":1615617738571,"gmtModify":1620443994056,"name":"StansenSG","pinyin":"stansensg","introduction":"","introductionEn":"","signature":"health is wealth","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":287,"headSize":141,"tweetSize":322,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.15","exceedPercentage":"93.25%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.14%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":685611246,"gmtCreate":1659602628188,"gmtModify":1659603001396,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>buy buy before it run away","listText":"<a href=\"https://laohu8.com/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>buy buy before it run away","text":"$OVERSEA-CHINESE BANKING CORP(O39.SI)$buy buy before it run away","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/685611246","isVote":1,"tweetType":1,"viewCount":1365,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":617960944,"gmtCreate":1654004957489,"gmtModify":1704858535601,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>buy buy buy, now now now, time time time","listText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>buy buy buy, now now now, time time time","text":"$SoFi Technologies Inc.(SOFI)$buy buy buy, now now now, time time time","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/617960944","isVote":1,"tweetType":1,"viewCount":462,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639803512,"gmtCreate":1643231768223,"gmtModify":1643231770744,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/639803512","repostId":"1169601269","repostType":4,"repost":{"id":"1169601269","pubTimestamp":1643210489,"share":"https://www.laohu8.com/m/news/1169601269?lang=&edition=full","pubTime":"2022-01-26 23:21","market":"us","language":"en","title":"Don’t Get Grabby with Low-Potential Grab Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=1169601269","media":"InvestorPlace","summary":"GRAB stock is down for the count and sinking fast as investors recognize the company's fiscal issues","content":"<html><head></head><body><p>GRAB stock is down for the count and sinking fast as investors recognize the company&#39;s fiscal issues</p><p>Here’s something I’ll bet you didn’t know. At one point in time, Southeast Asian ride-hailing and delivery company <b>Grab Holdings</b> (NASDAQ:<b><u>GRAB</u></b>) represented the largest ever special purpose acquisition company merger (SPAC)to date. That’s mind-blowing when we consider that many U.S. investors haven’t even heard of GRAB stock.</p><p>The company is well-known in certain regions of the world, though. In fact, Grab is Southeast Asia’s largest ride-hailing and delivery company. It has operations in Singapore, Malaysia, Cambodia, Indonesia, Myanmar, Philippines, Thailand and Vietnam and serves more than 187 million users.</p><p>Yet, while Grab the company may be well-known in Southeast Asia, GRAB stock isn’t particularly popular on Wall Street. As we’ll see, it’s in imminent danger of becoming a penny stock, which can informally be defined as a stock that represents a small company and trades for less than $5 per share.</p><p>That’s a potential problem, and a deep dive into the company’s financials will paint a dark picture of a ride-hailing business with major issues. So, if you’re not yet convinced to stay on the sidelines, stick around and we’ll discover together just how much damage has already been done.</p><p><b>A Closer Look at GRAB Stock</b></p><p>Grab made its debuton the <b>Nasdaq</b> on Dec. 2, 2021, after the company reverse-merged with blank-check company Altimeter Growth Corp.</p><p>The stock started off near $9, and it was all downhill from there. By the end of 2021, the share price has already declined to around $7.</p><p>There was more pain ahead as GRAB stock tumbled to $5 and change on Jan. 21, 2022. To be honest, it’s too soon to establish any support levels for the stock.</p><p>Besides, support levels are established when a stock bounces off of a particular price level. When a stock just keeps falling, there’s no support to speak of.</p><p>Going forward, keep an eye on that critical $5 level. GRAB stock could easily plummet to new lows if the buyers can’t hold $5.</p><p><b>Big Company, Big Problems</b></p><p>With a market capitalization of almost $21 billion, prospective investors might assume that Grab Holdings is a surefire winner.</p><p>It’s a large company, but <i>InvestorPlace</i>contributor Alex Sirois pointed out some equally large problems that Grab Holdings will have to deal with.</p><p>As Sirois explained, “Widespread lockdowns in the region due to recurring waves of COVID-19 have hurt demand for Grab’s ride-hailing services and weighed on revenue despite an increase in food-delivery volumes.”</p><p>We’ll discuss the financial issues in a moment. Sirois’s concerns about Covid-19 in Southeast Asia are duly noted, though – and they’re echoed by some big-bank analysts, apparently.</p><p>Reportedly, analysts at Asian Development Bank expect that Southeast Asian economies will recover at “a much slower pace” than previously thought.</p><p><b>Lockdowns Weighing on Revenues</b></p><p>This, as you might have surmised, is due to the recurrence of Covid-19 in the region. In 2022, the Asian Development Bank analysts expect Southeast Asia to grow by only 5%, slightly lower than their previous forecast.</p><p>Clearly, Covid-19 lockdowns have been a problem for Grab Holdings and could continue to weigh on the company’s revenue and earnings.</p><p>Indeed, for 2021’s third quarter, Grab Holdings acknowledged that the company’s revenue was down 9% year-over-year “as a result of a decline in mobility due to the severe lockdowns in Vietnam.”</p><p>Turning to the bottom-line results, Grab Holdings’ third-quarter 2021 earnings loss increased $366 million, to a staggering loss of $988 million.</p><p>Hence, investors should steer clear as a nearly billion-dollar quarterly earnings loss is quite worrisome.</p><p><b>The Takeaway</b></p><p>Admittedly, Grab Holdings is a famous company in Southeast Asia. It’s a large business, as we’ve learned, with a sizable market capitalization.</p><p>Yet, this company has major problems. In particular, Covid-19 creates challenges for businesses in Southeast Asia right now.</p><p>Then, there are the financial issues. Grab Holdings is moving in the wrong direction when it comes to revenue and earnings.</p><p>It’s understandable if you want to diversify your investments into different world regions. However, not all international stocks are equally worthy of your investment capital.</p><p>So, it’s probably a good idea to avoid GRAB stock for the time being. You can always check back later to see if the company’s financial situation improves.</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Don’t Get Grabby with Low-Potential Grab Holdings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDon’t Get Grabby with Low-Potential Grab Holdings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-26 23:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/01/dont-get-grabby-now-with-low-potential-grab-stock/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GRAB stock is down for the count and sinking fast as investors recognize the company's fiscal issuesHere’s something I’ll bet you didn’t know. At one point in time, Southeast Asian ride-hailing and ...</p>\n\n<a href=\"https://investorplace.com/2022/01/dont-get-grabby-now-with-low-potential-grab-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"source_url":"https://investorplace.com/2022/01/dont-get-grabby-now-with-low-potential-grab-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169601269","content_text":"GRAB stock is down for the count and sinking fast as investors recognize the company's fiscal issuesHere’s something I’ll bet you didn’t know. At one point in time, Southeast Asian ride-hailing and delivery company Grab Holdings (NASDAQ:GRAB) represented the largest ever special purpose acquisition company merger (SPAC)to date. That’s mind-blowing when we consider that many U.S. investors haven’t even heard of GRAB stock.The company is well-known in certain regions of the world, though. In fact, Grab is Southeast Asia’s largest ride-hailing and delivery company. It has operations in Singapore, Malaysia, Cambodia, Indonesia, Myanmar, Philippines, Thailand and Vietnam and serves more than 187 million users.Yet, while Grab the company may be well-known in Southeast Asia, GRAB stock isn’t particularly popular on Wall Street. As we’ll see, it’s in imminent danger of becoming a penny stock, which can informally be defined as a stock that represents a small company and trades for less than $5 per share.That’s a potential problem, and a deep dive into the company’s financials will paint a dark picture of a ride-hailing business with major issues. So, if you’re not yet convinced to stay on the sidelines, stick around and we’ll discover together just how much damage has already been done.A Closer Look at GRAB StockGrab made its debuton the Nasdaq on Dec. 2, 2021, after the company reverse-merged with blank-check company Altimeter Growth Corp.The stock started off near $9, and it was all downhill from there. By the end of 2021, the share price has already declined to around $7.There was more pain ahead as GRAB stock tumbled to $5 and change on Jan. 21, 2022. To be honest, it’s too soon to establish any support levels for the stock.Besides, support levels are established when a stock bounces off of a particular price level. When a stock just keeps falling, there’s no support to speak of.Going forward, keep an eye on that critical $5 level. GRAB stock could easily plummet to new lows if the buyers can’t hold $5.Big Company, Big ProblemsWith a market capitalization of almost $21 billion, prospective investors might assume that Grab Holdings is a surefire winner.It’s a large company, but InvestorPlacecontributor Alex Sirois pointed out some equally large problems that Grab Holdings will have to deal with.As Sirois explained, “Widespread lockdowns in the region due to recurring waves of COVID-19 have hurt demand for Grab’s ride-hailing services and weighed on revenue despite an increase in food-delivery volumes.”We’ll discuss the financial issues in a moment. Sirois’s concerns about Covid-19 in Southeast Asia are duly noted, though – and they’re echoed by some big-bank analysts, apparently.Reportedly, analysts at Asian Development Bank expect that Southeast Asian economies will recover at “a much slower pace” than previously thought.Lockdowns Weighing on RevenuesThis, as you might have surmised, is due to the recurrence of Covid-19 in the region. In 2022, the Asian Development Bank analysts expect Southeast Asia to grow by only 5%, slightly lower than their previous forecast.Clearly, Covid-19 lockdowns have been a problem for Grab Holdings and could continue to weigh on the company’s revenue and earnings.Indeed, for 2021’s third quarter, Grab Holdings acknowledged that the company’s revenue was down 9% year-over-year “as a result of a decline in mobility due to the severe lockdowns in Vietnam.”Turning to the bottom-line results, Grab Holdings’ third-quarter 2021 earnings loss increased $366 million, to a staggering loss of $988 million.Hence, investors should steer clear as a nearly billion-dollar quarterly earnings loss is quite worrisome.The TakeawayAdmittedly, Grab Holdings is a famous company in Southeast Asia. It’s a large business, as we’ve learned, with a sizable market capitalization.Yet, this company has major problems. In particular, Covid-19 creates challenges for businesses in Southeast Asia right now.Then, there are the financial issues. Grab Holdings is moving in the wrong direction when it comes to revenue and earnings.It’s understandable if you want to diversify your investments into different world regions. However, not all international stocks are equally worthy of your investment capital.So, it’s probably a good idea to avoid GRAB stock for the time being. You can always check back later to see if the company’s financial situation improves.","news_type":1},"isVote":1,"tweetType":1,"viewCount":868,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630254667,"gmtCreate":1642934108176,"gmtModify":1642934110949,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/630254667","repostId":"1138349004","repostType":4,"repost":{"id":"1138349004","pubTimestamp":1642896014,"share":"https://www.laohu8.com/m/news/1138349004?lang=&edition=full","pubTime":"2022-01-23 08:00","market":"us","language":"en","title":"US IPO Weekly Recap: No IPOs as Postponements and Pricing Delays Abound","url":"https://stock-news.laohu8.com/highlight/detail?id=1138349004","media":"Renaissance Capital","summary":"Challenging conditions in the IPO market continued this past week. The two major deals on the calend","content":"<html><head></head><body><p>Challenging conditions in the IPO market continued this past week. The two major deals on the calendar postponed, and the remaining micro-caps pushed back their debuts by a week. Seven SPACs completed offerings, and three IPOs and four SPACs submitted initial filings.</p><p><b>Four Springs Capital Trust</b>(FSPR) postponed its $252 million IPO, which was set to be the largest deal of the week. The REIT previously attempted to go public in 2017, and had expanded its portfolio since then. Bitcoin miner<b>Rhodium Enterprises</b>(RHDM) postponed its $100 million IPO as Bitcoin prices continue to drop.</p><p>Seven SPACS went public this past week led by Hondius Capital’s<b>HCM Acquisition</b>(HCMAU), which raised $250 million to target the fintech sector.</p><p>While not included below, Japan-based<b>Yoshitsu</b>(TKLF) began trading after initially pricing its IPO earlier this month. The retailer became the latest micro-cap to soar on its debut, gaining 700% on its first day; it finished the week up 638%.</p><p><img src=\"https://static.tigerbbs.com/f5483ea5b543cd470959591e2016fe0a\" tg-width=\"1471\" tg-height=\"712\" referrerpolicy=\"no-referrer\"/></p><p>Three IPOs submitted initial filings. RIA services platform<b>Dynasty Financial Partners</b>(DSTY) filed to raise $100 million, Chinese insurance firm<b>Hengguang Holding</b>(HGIA) filed to raise $20 million, and Chinese micro-cap<b>Erayak Power Solution Group</b>(RAYA) filed to raise $15 million.</p><p>Four SPACs submitted initial filings. Auto-focused<b>Kensington Capital Acquisition IV</b>(KCAC.U), Intrepid Potash’s<b>Intrepid Acquisition I</b>(IACIU), and life sciences and sustainability-focused<b>Valuence Merger I</b>(VMCAU) all filed to raise $200 million.</p><p><img src=\"https://static.tigerbbs.com/241e940f6136f3bf1b4e6cc056743aa2\" tg-width=\"1478\" tg-height=\"713\" referrerpolicy=\"no-referrer\"/></p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: No IPOs as Postponements and Pricing Delays Abound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: No IPOs as Postponements and Pricing Delays Abound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-23 08:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/90388/US-IPO-Weekly-Recap-No-IPOs-as-postponements-and-pricing-delays-abound><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Challenging conditions in the IPO market continued this past week. The two major deals on the calendar postponed, and the remaining micro-caps pushed back their debuts by a week. Seven SPACs completed...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/90388/US-IPO-Weekly-Recap-No-IPOs-as-postponements-and-pricing-delays-abound\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","TKLF":"Yoshitsu Co., Ltd."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/90388/US-IPO-Weekly-Recap-No-IPOs-as-postponements-and-pricing-delays-abound","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138349004","content_text":"Challenging conditions in the IPO market continued this past week. The two major deals on the calendar postponed, and the remaining micro-caps pushed back their debuts by a week. Seven SPACs completed offerings, and three IPOs and four SPACs submitted initial filings.Four Springs Capital Trust(FSPR) postponed its $252 million IPO, which was set to be the largest deal of the week. The REIT previously attempted to go public in 2017, and had expanded its portfolio since then. Bitcoin minerRhodium Enterprises(RHDM) postponed its $100 million IPO as Bitcoin prices continue to drop.Seven SPACS went public this past week led by Hondius Capital’sHCM Acquisition(HCMAU), which raised $250 million to target the fintech sector.While not included below, Japan-basedYoshitsu(TKLF) began trading after initially pricing its IPO earlier this month. The retailer became the latest micro-cap to soar on its debut, gaining 700% on its first day; it finished the week up 638%.Three IPOs submitted initial filings. RIA services platformDynasty Financial Partners(DSTY) filed to raise $100 million, Chinese insurance firmHengguang Holding(HGIA) filed to raise $20 million, and Chinese micro-capErayak Power Solution Group(RAYA) filed to raise $15 million.Four SPACs submitted initial filings. Auto-focusedKensington Capital Acquisition IV(KCAC.U), Intrepid Potash’sIntrepid Acquisition I(IACIU), and life sciences and sustainability-focusedValuence Merger I(VMCAU) all filed to raise $200 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":610,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630390897,"gmtCreate":1642687953408,"gmtModify":1642687955968,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/630390897","repostId":"1105143250","repostType":4,"repost":{"id":"1105143250","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642686991,"share":"https://www.laohu8.com/m/news/1105143250?lang=&edition=full","pubTime":"2022-01-20 21:56","market":"us","language":"en","title":"Novavax Covid-19 Vaccine Cleared in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=1105143250","media":"Tiger Newspress","summary":"Novavax shares rose over 2% premarket as Australia's Therapeutic Goods Administration (TGA) had gran","content":"<html><head></head><body><p>Novavax shares rose over 2% premarket as Australia&#39;s Therapeutic Goods Administration (TGA) had granted the approval of Novavax Covid-19 vaccine.</p><p><img src=\"https://static.tigerbbs.com/8bd516836472463166488720fec8e99f\" tg-width=\"852\" tg-height=\"650\" referrerpolicy=\"no-referrer\"/></p><p>Australia&#39;s Therapeutic Goods Administration (TGA) has granted the approval for provisional registration of the COVID-19 vaccine developed by <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> for those aged 18 years and above, the company announced Thursday.</p><p>The country will receive the vaccine shipments under the brand name Nuvaxovid.</p><p>Last year, Novavax (NVAX) announced an advance purchase agreement (APA) with Australia for 51M doses of the vaccine including an option to deliver additional 10M doses. Serum Institute of India (SII), the world&#39;s largest vaccine manufacturer is set to supply the initial doses to Australia.</p><p>&#34;The grant of provisional registration of Nuvaxovid by the TGA reflects Novavax&#39;s increasing momentum around the globe and represents the first-protein based COVID-19 vaccine authorized for use in Australia,&#34; said Novavax (NVAX) CEO Stanley C. Erck.</p><p>In December, the company’s COVID-19 vaccine identified as NVX-CoV2373 was cleared by multiple regulatory agencies, including the European Medicines Agency (EMA) and the World Health Organization.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Covid-19 Vaccine Cleared in Australia</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Covid-19 Vaccine Cleared in Australia\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-20 21:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Novavax shares rose over 2% premarket as Australia&#39;s Therapeutic Goods Administration (TGA) had granted the approval of Novavax Covid-19 vaccine.</p><p><img src=\"https://static.tigerbbs.com/8bd516836472463166488720fec8e99f\" tg-width=\"852\" tg-height=\"650\" referrerpolicy=\"no-referrer\"/></p><p>Australia&#39;s Therapeutic Goods Administration (TGA) has granted the approval for provisional registration of the COVID-19 vaccine developed by <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> for those aged 18 years and above, the company announced Thursday.</p><p>The country will receive the vaccine shipments under the brand name Nuvaxovid.</p><p>Last year, Novavax (NVAX) announced an advance purchase agreement (APA) with Australia for 51M doses of the vaccine including an option to deliver additional 10M doses. Serum Institute of India (SII), the world&#39;s largest vaccine manufacturer is set to supply the initial doses to Australia.</p><p>&#34;The grant of provisional registration of Nuvaxovid by the TGA reflects Novavax&#39;s increasing momentum around the globe and represents the first-protein based COVID-19 vaccine authorized for use in Australia,&#34; said Novavax (NVAX) CEO Stanley C. Erck.</p><p>In December, the company’s COVID-19 vaccine identified as NVX-CoV2373 was cleared by multiple regulatory agencies, including the European Medicines Agency (EMA) and the World Health Organization.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105143250","content_text":"Novavax shares rose over 2% premarket as Australia's Therapeutic Goods Administration (TGA) had granted the approval of Novavax Covid-19 vaccine.Australia's Therapeutic Goods Administration (TGA) has granted the approval for provisional registration of the COVID-19 vaccine developed by Novavax  for those aged 18 years and above, the company announced Thursday.The country will receive the vaccine shipments under the brand name Nuvaxovid.Last year, Novavax (NVAX) announced an advance purchase agreement (APA) with Australia for 51M doses of the vaccine including an option to deliver additional 10M doses. Serum Institute of India (SII), the world's largest vaccine manufacturer is set to supply the initial doses to Australia.\"The grant of provisional registration of Nuvaxovid by the TGA reflects Novavax's increasing momentum around the globe and represents the first-protein based COVID-19 vaccine authorized for use in Australia,\" said Novavax (NVAX) CEO Stanley C. Erck.In December, the company’s COVID-19 vaccine identified as NVX-CoV2373 was cleared by multiple regulatory agencies, including the European Medicines Agency (EMA) and the World Health Organization.","news_type":1},"isVote":1,"tweetType":1,"viewCount":884,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697615926,"gmtCreate":1642439826857,"gmtModify":1642439837906,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/697615926","repostId":"1177851470","repostType":4,"repost":{"id":"1177851470","pubTimestamp":1642430618,"share":"https://www.laohu8.com/m/news/1177851470?lang=&edition=full","pubTime":"2022-01-17 22:43","market":"us","language":"en","title":"Is Microsoft's Stock Overvalued Or Undervalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=1177851470","media":"Benzinga","summary":"$Microsoft Corporation(MSFT)$ shares have outperformed the S&P 500 in the past year, generating a to","content":"<html><head></head><body><p>$<b>Microsoft Corporation(</b>MSFT)$ shares have outperformed the S&amp;P 500 in the past year, generating a total return of 42%.</p><p>Microsoft is still putting up impressive growth numbers. But with a $2.31 trillion market cap, some investors are wondering if there’s any value left in Microsoft stock.</p><p><b>Earnings:</b> A price-to-earnings ratio (PE) is one of the most basic fundamental metrics for gauging a stock’s value. The lower the PE, the higher the value. For comparison, the S&amp;P 500’s PE is currently at about 29.5, nearly double its long-term average of 15.6.</p><p><b>Microsoft’s PE is currently 34.0, slightly higher than the S&amp;P 500 average as a whole. Microsoft’s PE is also up 30.3% over the past five years, suggesting its earnings multiple is on the high end of its historical range.</b></p><p><b>Growth:</b> Looking ahead to the next four quarters, the S&amp;P 500’s forward PE ratio looks much more reasonable at just 20.9. <b>Unfortunately, Microsoft’s forward earnings ratio of 28.8 doesn’t make the stock undervalued at its current price.</b> In fact, it appears to be slightly overvalued compared to technology sectorpeers that are currently averaging a 27.9 forward earnings multiple.</p><p>However, when it comes to evaluating a stock, earnings aren&#39;t everything.</p><p>Growth rate is also critical for companies that are rapidly building their bottom lines. The price-to-earnings-to-growth ratio (PEG) is a good way to incorporate growth rates into the evaluation process. The S&amp;P 500’s overall PEG is currently about 1; Microsoft’s PEG is 2.0, a potential red flag that the stock has become overheated.</p><p>Price-to-sales ratio is another important valuation metric, particularly for unprofitable companies and growth stocks. The S&amp;P 500’s PS ratio is currently 3.21, nearly twice its long-term average of 1.63. Microsoft’s PS ratio is 12.98, definitely not what a value investor is looking for.</p><p>Finally, Wall Street analysts see decent gains for Microsoft shares over the next 12 months.<b>The average analyst price target among the 36 analysts covering Microsoft is $370, suggesting about 20.4% upside from current levels.</b></p><p><b>The Verdict:</b> At its current valuation, Microsoft stock is showing a couple of warning signs of being overvalued, so investors should proceed with caution.</p></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Microsoft's Stock Overvalued Or Undervalued?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Microsoft's Stock Overvalued Or Undervalued?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-17 22:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/education/22/01/25061574/is-microsofts-stock-overvalued-or-undervalued><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>$Microsoft Corporation(MSFT)$ shares have outperformed the S&P 500 in the past year, generating a total return of 42%.Microsoft is still putting up impressive growth numbers. But with a $2.31 trillion...</p>\n\n<a href=\"https://www.benzinga.com/general/education/22/01/25061574/is-microsofts-stock-overvalued-or-undervalued\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软"},"source_url":"https://www.benzinga.com/general/education/22/01/25061574/is-microsofts-stock-overvalued-or-undervalued","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177851470","content_text":"$Microsoft Corporation(MSFT)$ shares have outperformed the S&P 500 in the past year, generating a total return of 42%.Microsoft is still putting up impressive growth numbers. But with a $2.31 trillion market cap, some investors are wondering if there’s any value left in Microsoft stock.Earnings: A price-to-earnings ratio (PE) is one of the most basic fundamental metrics for gauging a stock’s value. The lower the PE, the higher the value. For comparison, the S&P 500’s PE is currently at about 29.5, nearly double its long-term average of 15.6.Microsoft’s PE is currently 34.0, slightly higher than the S&P 500 average as a whole. Microsoft’s PE is also up 30.3% over the past five years, suggesting its earnings multiple is on the high end of its historical range.Growth: Looking ahead to the next four quarters, the S&P 500’s forward PE ratio looks much more reasonable at just 20.9. Unfortunately, Microsoft’s forward earnings ratio of 28.8 doesn’t make the stock undervalued at its current price. In fact, it appears to be slightly overvalued compared to technology sectorpeers that are currently averaging a 27.9 forward earnings multiple.However, when it comes to evaluating a stock, earnings aren't everything.Growth rate is also critical for companies that are rapidly building their bottom lines. The price-to-earnings-to-growth ratio (PEG) is a good way to incorporate growth rates into the evaluation process. The S&P 500’s overall PEG is currently about 1; Microsoft’s PEG is 2.0, a potential red flag that the stock has become overheated.Price-to-sales ratio is another important valuation metric, particularly for unprofitable companies and growth stocks. The S&P 500’s PS ratio is currently 3.21, nearly twice its long-term average of 1.63. Microsoft’s PS ratio is 12.98, definitely not what a value investor is looking for.Finally, Wall Street analysts see decent gains for Microsoft shares over the next 12 months.The average analyst price target among the 36 analysts covering Microsoft is $370, suggesting about 20.4% upside from current levels.The Verdict: At its current valuation, Microsoft stock is showing a couple of warning signs of being overvalued, so investors should proceed with caution.","news_type":1},"isVote":1,"tweetType":1,"viewCount":787,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697355365,"gmtCreate":1642308720456,"gmtModify":1642308722972,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/697355365","repostId":"1161593163","repostType":4,"isVote":1,"tweetType":1,"viewCount":676,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697951929,"gmtCreate":1642230828950,"gmtModify":1642230831460,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/697951929","repostId":"2203714737","repostType":4,"repost":{"id":"2203714737","pubTimestamp":1642211689,"share":"https://www.laohu8.com/m/news/2203714737?lang=&edition=full","pubTime":"2022-01-15 09:54","market":"us","language":"en","title":"Procter & Gamble Q2 Earnings Preview: Will Inflation Take a Bigger Bite Out of Profits?","url":"https://stock-news.laohu8.com/highlight/detail?id=2203714737","media":"Motley Fool","summary":"The consumer packaged goods giant is grappling with rising costs as inflation rattles world economies.","content":"<html><head></head><body><p>International consumer packaged goods giant <b>Procter &amp; Gamble</b> (NYSE:PG) is scheduled to report fiscal 2022 second-quarter earnings on Jan. 19. While sales have been increasing since the pandemic onset, Procter &amp; Gamble (P&amp;G) is grappling with the pressures from rising costs as economies are reopening.</p><p>The coronavirus pandemic is causing shortages of workers in all parts of the world, as fewer people are willing to work or governments aren&#39;t allowing them to work while a potentially deadly virus is still circulating aggressively. The company has already warned the market of the magnitude of harm that inflation will do to profits. Investors will be tuning in to P&amp;G&#39;s second-quarter results next Wednesday, looking at how accurate management&#39;s predictions were.</p><h2>Inflation is taking a bite out of P&amp;G&#39;s profits</h2><p>Procter &amp; Gamble sells a host of popular products that are used at home, including Tide detergent, Bounty paper towels, and Oral-B teeth cleaning products. The coronavirus pandemic caused billions of people to spend more time at home. Unsurprisingly, this helped boost the sales of P&amp;G products, which have a lot of brand recognition and trust among consumers. In 2020 and 2021, revenue increased by 4.8% and 7.3%, respectively. The aforementioned were the highest growth rates for P&amp;G in the last decade.</p><p>Management expects this robust sales growth to continue in fiscal 2022. It guided to a range of 2% to 4%, and after the excellent results in the first quarter (ended Sept. 30), management said it thinks the higher end of that range is more likely. The more significant challenge for P&amp;G will be on the cost side of things. Here&#39;s what CFO Andre Schulten said on the matter in the company&#39;s first-quarter conference call:</p><blockquote>Input costs have continued to rise since we gave our initial outlook for the year in late July. Based on current spot prices, we now estimate a $2.1 billion after-tax commodity cost headwind in fiscal 2022. Fiscal cost -- freight costs have also continued to increase. We now expect freight and transportation costs to be an incremental $200 million after-tax headwind in fiscal &#39;22. We will offset a portion of these higher costs with price increases and with productivity savings.</blockquote><p>Already, in P&amp;G&#39;s first quarter, it experienced a 400-basis-point hit to gross margins from higher prices paid for commodities and shipping. With the omicron variant creating yet another wave of rising coronavirus infection, labor and materials shortages are likely to persist at least a bit longer. Interestingly, the guidance for $2.3 billion of incremental costs due to rising inflation was before the most recent COVID-19 wave. That means there is a chance that management could revise the figure even higher when the company reports Q2 results.</p><h2>What this could mean for investors</h2><p>Analysts on Wall Street expect Procter &amp; Gamble to report revenue of $20.4 billion and earnings per share (EPS) of $1.66 in Q2. If the company hits the EPS estimate on Wall Street, it could be an increase of just 1.2% from the same quarter last year.</p><p>That would be below the pace of 3% to 6% EPS growth management has guided for 2022, but it also noted that most gains would flow in the second half of the year after price increases go into effect. Investors should stay tuned and see if management changes the yearly forecast after Q2 results are announced on Wednesday.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Procter & Gamble Q2 Earnings Preview: Will Inflation Take a Bigger Bite Out of Profits?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProcter & Gamble Q2 Earnings Preview: Will Inflation Take a Bigger Bite Out of Profits?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-15 09:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/14/proctor-gamble-q2-earnings-preview-inflation/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>International consumer packaged goods giant Procter & Gamble (NYSE:PG) is scheduled to report fiscal 2022 second-quarter earnings on Jan. 19. While sales have been increasing since the pandemic onset,...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/14/proctor-gamble-q2-earnings-preview-inflation/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PG":"宝洁","QTWO":"Q2 Holdings Inc"},"source_url":"https://www.fool.com/investing/2022/01/14/proctor-gamble-q2-earnings-preview-inflation/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2203714737","content_text":"International consumer packaged goods giant Procter & Gamble (NYSE:PG) is scheduled to report fiscal 2022 second-quarter earnings on Jan. 19. While sales have been increasing since the pandemic onset, Procter & Gamble (P&G) is grappling with the pressures from rising costs as economies are reopening.The coronavirus pandemic is causing shortages of workers in all parts of the world, as fewer people are willing to work or governments aren't allowing them to work while a potentially deadly virus is still circulating aggressively. The company has already warned the market of the magnitude of harm that inflation will do to profits. Investors will be tuning in to P&G's second-quarter results next Wednesday, looking at how accurate management's predictions were.Inflation is taking a bite out of P&G's profitsProcter & Gamble sells a host of popular products that are used at home, including Tide detergent, Bounty paper towels, and Oral-B teeth cleaning products. The coronavirus pandemic caused billions of people to spend more time at home. Unsurprisingly, this helped boost the sales of P&G products, which have a lot of brand recognition and trust among consumers. In 2020 and 2021, revenue increased by 4.8% and 7.3%, respectively. The aforementioned were the highest growth rates for P&G in the last decade.Management expects this robust sales growth to continue in fiscal 2022. It guided to a range of 2% to 4%, and after the excellent results in the first quarter (ended Sept. 30), management said it thinks the higher end of that range is more likely. The more significant challenge for P&G will be on the cost side of things. Here's what CFO Andre Schulten said on the matter in the company's first-quarter conference call:Input costs have continued to rise since we gave our initial outlook for the year in late July. Based on current spot prices, we now estimate a $2.1 billion after-tax commodity cost headwind in fiscal 2022. Fiscal cost -- freight costs have also continued to increase. We now expect freight and transportation costs to be an incremental $200 million after-tax headwind in fiscal '22. We will offset a portion of these higher costs with price increases and with productivity savings.Already, in P&G's first quarter, it experienced a 400-basis-point hit to gross margins from higher prices paid for commodities and shipping. With the omicron variant creating yet another wave of rising coronavirus infection, labor and materials shortages are likely to persist at least a bit longer. Interestingly, the guidance for $2.3 billion of incremental costs due to rising inflation was before the most recent COVID-19 wave. That means there is a chance that management could revise the figure even higher when the company reports Q2 results.What this could mean for investorsAnalysts on Wall Street expect Procter & Gamble to report revenue of $20.4 billion and earnings per share (EPS) of $1.66 in Q2. If the company hits the EPS estimate on Wall Street, it could be an increase of just 1.2% from the same quarter last year.That would be below the pace of 3% to 6% EPS growth management has guided for 2022, but it also noted that most gains would flow in the second half of the year after price increases go into effect. Investors should stay tuned and see if management changes the yearly forecast after Q2 results are announced on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":912,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696351122,"gmtCreate":1640624037578,"gmtModify":1640624040127,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/696351122","repostId":"1102433799","repostType":4,"repost":{"id":"1102433799","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640617949,"share":"https://www.laohu8.com/m/news/1102433799?lang=&edition=full","pubTime":"2021-12-27 23:12","market":"us","language":"en","title":"Gaming stocks rose in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1102433799","media":"Tiger Newspress","summary":"Gaming stocks rose in morning trading.Roblox,Unity Software&nbsp;and&nbsp;AppLovin&nbsp;climbed between 1% and 3%.","content":"<p>Gaming stocks rose in morning trading.Roblox,Unity Software&nbsp;and&nbsp;AppLovin&nbsp;climbed between 1% and 3%.</p>\n<p><img src=\"https://static.tigerbbs.com/580cc77260d26ccb370ef7f324be78b5\" tg-width=\"419\" tg-height=\"419\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gaming stocks rose in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGaming stocks rose in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-27 23:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Gaming stocks rose in morning trading.Roblox,Unity Software&nbsp;and&nbsp;AppLovin&nbsp;climbed between 1% and 3%.</p>\n<p><img src=\"https://static.tigerbbs.com/580cc77260d26ccb370ef7f324be78b5\" tg-width=\"419\" tg-height=\"419\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RBLX":"Roblox Corporation"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102433799","content_text":"Gaming stocks rose in morning trading.Roblox,Unity Software and AppLovin climbed between 1% and 3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":749,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698732578,"gmtCreate":1640533448999,"gmtModify":1640533451562,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698732578","repostId":"1144001147","repostType":4,"repost":{"id":"1144001147","pubTimestamp":1640485026,"share":"https://www.laohu8.com/m/news/1144001147?lang=&edition=full","pubTime":"2021-12-26 10:17","market":"us","language":"en","title":"A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State","url":"https://stock-news.laohu8.com/highlight/detail?id=1144001147","media":"InvestorPlace","summary":"In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, t","content":"<p>In the last year,&nbsp;<b>Ocugen</b>(NASDAQ:<b><u>OCGN</u></b>) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there, the stock is up over 1,600%.</p>\n<p>However, it’s worth noting that OCGN stock was trading well below one dollar before it stitched a partnership with&nbsp;<b>Bharat Biotech</b>. The companies announced plans to begin manufacturing Covid-19 vaccines in the U.S. on Dec. 22 last year.</p>\n<p>Beyond the news of this partnership, there has been little to cheer for investors. OCGN stock traded at all-time highs of $18.77 in February and reached slightly lower peaks in May and November. The stock traded at $5.12 at the start of Dec. 23.</p>\n<p>Ocugen will continue to underperform going forward. Even after the downtrend in the last few months, OCGN stock should be avoided.</p>\n<p>Let’s talk about the reasons to be bearish.</p>\n<p>FDA Approval Remains Elusive</p>\n<p><b>Pfizer</b>(NYSE:<b><u>PFE</u></b>) and&nbsp;<b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>) have been leaders in the vaccine race in the U.S. In a country where more than 70% of the population has already been vaccinated, Ocugen has yet to secure an approval from the U.S. Food and Drug Administration.</p>\n<p>Back in June, the biotech company’s&nbsp;application for emergency use authorization&nbsp;was rejected by the FDA. The recommendation by the FDA was to file for a biologics license application, which implies full approval.</p>\n<p>In November, Ocugen announced that the FDA has “issued a clinical hold&nbsp;on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate.” The FDA will be identifying the specific deficiencies that form a basis for the clinical hold. Once Ocugen addresses these deficiencies, there will be some progress.</p>\n<p>The key point is that it’s been over a year since Ocugen announced the partnership with Bharat Biotech. The company has still been unsuccessful from an approval perspective.</p>\n<p>In July, Ocugen had also initiated a&nbsp;rolling submission to Health Canada&nbsp;for the vaccine. There is no positive news on that front either.</p>\n<p>Let’s imagine a scenario where Ocugen receives an approval for vaccine use in Q1 2022. This is very unlikely. However, even in an optimistic case scenario, Ocugen needs to compete in a market where vaccination percentage is high. There is unlikely to be a case for strong revenue and cash flow growth.</p>\n<p>Can Omicron Provide a Lifeline for OCGN Stock?</p>\n<p>The omicron variant has been a cause of concern for governments globally. Ocugen and partner Bharat Biotech are&nbsp;currently studying the effectiveness&nbsp;of the vaccine against the variant.</p>\n<p>If the vaccine proves to be effective, can it be a game-changer for Ocugen? Most likely, no.</p>\n<p>First and foremost, Moderna has announced that its Covid-19 booster&nbsp;increases neutralizing antibodies 37-fold&nbsp;against Omicron variant.</p>\n<p>Furthermore, Pfizer has announced that a third dose increases the “neutralizing antibody by 25-fold&nbsp;compared to two doses against the Omicron variant.”</p>\n<p>Clearly, the leading vaccine makers have an edge. Even if Ocugen announces that its vaccine is effective against the omicron variant, the stock is unlikely to trend higher.</p>\n<p>People who have already taken two shots of Moderna or Pfizer are unlikely to pursue a booster shot with Ocugen. Additionally, Ocugen is still struggling for approval.</p>\n<p>It’s also worth noting that Ocugen needs to share revenue with Bharat Biotech. The visibility for healthy cash flows is therefore very unlikely.</p>\n<p>OCGN Stock Will Trend Lower</p>\n<p>OCGN stock is likely to continue trending lower in the coming months. Without an approval, the company is rapidly losing out on any revenue and cash flow potential.</p>\n<p>The company is&nbsp;building a pipeline of drugs&nbsp;for various indications. However, the pipeline for various indications is still at a pre-clinical stage.</p>\n<p>The stock trend will therefore be dictated by the outcome of Covid-19 vaccine approval and revenue potential. Things seem bleak on that front.</p>\n<p>It also seems unlikely that Ocugen has a capability to expand the vaccine partnership with Bharat Biotech to other countries.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Year After Announcing a Big Partnership, Ocugen Is in a Sorry State\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 10:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there...</p>\n\n<a href=\"https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144001147","content_text":"In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there, the stock is up over 1,600%.\nHowever, it’s worth noting that OCGN stock was trading well below one dollar before it stitched a partnership with Bharat Biotech. The companies announced plans to begin manufacturing Covid-19 vaccines in the U.S. on Dec. 22 last year.\nBeyond the news of this partnership, there has been little to cheer for investors. OCGN stock traded at all-time highs of $18.77 in February and reached slightly lower peaks in May and November. The stock traded at $5.12 at the start of Dec. 23.\nOcugen will continue to underperform going forward. Even after the downtrend in the last few months, OCGN stock should be avoided.\nLet’s talk about the reasons to be bearish.\nFDA Approval Remains Elusive\nPfizer(NYSE:PFE) and Moderna(NASDAQ:MRNA) have been leaders in the vaccine race in the U.S. In a country where more than 70% of the population has already been vaccinated, Ocugen has yet to secure an approval from the U.S. Food and Drug Administration.\nBack in June, the biotech company’s application for emergency use authorization was rejected by the FDA. The recommendation by the FDA was to file for a biologics license application, which implies full approval.\nIn November, Ocugen announced that the FDA has “issued a clinical hold on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate.” The FDA will be identifying the specific deficiencies that form a basis for the clinical hold. Once Ocugen addresses these deficiencies, there will be some progress.\nThe key point is that it’s been over a year since Ocugen announced the partnership with Bharat Biotech. The company has still been unsuccessful from an approval perspective.\nIn July, Ocugen had also initiated a rolling submission to Health Canada for the vaccine. There is no positive news on that front either.\nLet’s imagine a scenario where Ocugen receives an approval for vaccine use in Q1 2022. This is very unlikely. However, even in an optimistic case scenario, Ocugen needs to compete in a market where vaccination percentage is high. There is unlikely to be a case for strong revenue and cash flow growth.\nCan Omicron Provide a Lifeline for OCGN Stock?\nThe omicron variant has been a cause of concern for governments globally. Ocugen and partner Bharat Biotech are currently studying the effectiveness of the vaccine against the variant.\nIf the vaccine proves to be effective, can it be a game-changer for Ocugen? Most likely, no.\nFirst and foremost, Moderna has announced that its Covid-19 booster increases neutralizing antibodies 37-fold against Omicron variant.\nFurthermore, Pfizer has announced that a third dose increases the “neutralizing antibody by 25-fold compared to two doses against the Omicron variant.”\nClearly, the leading vaccine makers have an edge. Even if Ocugen announces that its vaccine is effective against the omicron variant, the stock is unlikely to trend higher.\nPeople who have already taken two shots of Moderna or Pfizer are unlikely to pursue a booster shot with Ocugen. Additionally, Ocugen is still struggling for approval.\nIt’s also worth noting that Ocugen needs to share revenue with Bharat Biotech. The visibility for healthy cash flows is therefore very unlikely.\nOCGN Stock Will Trend Lower\nOCGN stock is likely to continue trending lower in the coming months. Without an approval, the company is rapidly losing out on any revenue and cash flow potential.\nThe company is building a pipeline of drugs for various indications. However, the pipeline for various indications is still at a pre-clinical stage.\nThe stock trend will therefore be dictated by the outcome of Covid-19 vaccine approval and revenue potential. Things seem bleak on that front.\nIt also seems unlikely that Ocugen has a capability to expand the vaccine partnership with Bharat Biotech to other countries.","news_type":1},"isVote":1,"tweetType":1,"viewCount":555,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698569131,"gmtCreate":1640457159831,"gmtModify":1640457162542,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698569131","repostId":"2193720178","repostType":4,"repost":{"id":"2193720178","pubTimestamp":1640398065,"share":"https://www.laohu8.com/m/news/2193720178?lang=&edition=full","pubTime":"2021-12-25 10:07","market":"us","language":"en","title":"2 Top Stocks to Buy for the New Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2193720178","media":"Motley Fool","summary":"Two very different companies -- one in tech and one in retail -- offer investors long-term growth potential and durable business models.","content":"<p>With talks of likely interest rate hikes from the Federal Reserve in 2022 and the coronavirus pandemic still making the rounds, one key characteristic investors should look for in investments going into the new year is resilience. In other words, some good traits to look for are valuations that make sense relative to a company's growth trajectory and market opportunity, and durable business models with proven track records. While there's no way to avoid volatility, owning resilient companies can at least help investors better weather near-term challenges (mentally and emotionally) since they know their investments have what it takes to endure.</p>\n<p>Two companies that fit this description are <b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b> (NASDAQ:FB) and <b><a href=\"https://laohu8.com/S/TSCO\">Tractor Supply Company</a></b> (NASDAQ:TSCO). Here's a look at why both of these stocks are good bets for 2022 and beyond.</p>\n<h2>Meta Platforms</h2>\n<p>The case for Meta Platforms is straightforward. The tech stock's valuation is very cheap relative to the company's recent growth. Consider that the Facebook parent's trailing-12-month revenue and net income of $112 billion and $40 billion, respectively, are up from $71 billion and $18 billion in 2019. Even with such staggering recent growth, Meta Platforms trades at only 24 times its current level of earnings.</p>\n<p>While the company is running into some near-term growth headwinds related to <b>Apple</b>'s recent changes to advertising tracking and measurement, it's not like the suppressed growth Meta Platforms is expecting is poor. Management guided for fourth-quarter revenue to be between $31.5 billion and $34 billion. The midpoint of this guidance range represents 17% revenue growth. Further, analysts are still modeling for exceptional earnings-per-share growth over the next five years. On average, analysts currently expect Meta Platforms' earnings per share to compound at a growth rate of 21% annually over this period.</p>\n<p>Meta Platforms' network effect of billions of monthly active users makes its business very durable. Not only has the company's core Facebook platform consistently grown larger with no close challenger, but the company's other social networks with more intense competition (namely Instagram) have shown they can easily deploy features that imitate successful competitors, helping them stay relevant.</p>\n<h2>Tractor Supply Company</h2>\n<p>Some city folk may have never even stepped foot in a Tractor Supply store. But investors shouldn't overlook this investment just because they're not familiar with the retailer. Tractor Supply, which specializes in rural lifestyle, has a strong retail niche and is capitalizing well on several different important growth catalysts, including private label and exclusive brands, pet food, and e-commerce. Its balanced business has helped revenue grow 24% year over year in the trailing 12 months, and helped earnings per share grow 22%.</p>\n<p>Tractor Supply is notably mastering e-commerce in a market where many of its customers live farther apart than people do in the city. These communities come with unique challenges that Tractor Supply is able to develop expertise in, and the company's strategy is working. Tractor Supply said on its most recent earnings call that its e-commerce sales increased at a rate faster than 40% year over year.</p>\n<p>While the stock's price-to-earnings ratio of 29 isn't exactly cheap, the company's positioning as the lead retailer for the rural lifestyle makes this business worth paying up for. Given how specialized Tractor Supply is, it would be very difficult for a competitor to topple it. The company also pays a dividend and is regularly repurchasing shares, supplementing shareholder value creation.</p>\n<p>Facebook and Tractor Supply together represent two solid ideas from very different industries that provide meaningful long-term growth potential for investors.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Top Stocks to Buy for the New Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Top Stocks to Buy for the New Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/2-top-stocks-to-buy-for-the-new-year/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With talks of likely interest rate hikes from the Federal Reserve in 2022 and the coronavirus pandemic still making the rounds, one key characteristic investors should look for in investments going ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/2-top-stocks-to-buy-for-the-new-year/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSCO":"拖拉机供应公司"},"source_url":"https://www.fool.com/investing/2021/12/24/2-top-stocks-to-buy-for-the-new-year/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193720178","content_text":"With talks of likely interest rate hikes from the Federal Reserve in 2022 and the coronavirus pandemic still making the rounds, one key characteristic investors should look for in investments going into the new year is resilience. In other words, some good traits to look for are valuations that make sense relative to a company's growth trajectory and market opportunity, and durable business models with proven track records. While there's no way to avoid volatility, owning resilient companies can at least help investors better weather near-term challenges (mentally and emotionally) since they know their investments have what it takes to endure.\nTwo companies that fit this description are Meta Platforms (NASDAQ:FB) and Tractor Supply Company (NASDAQ:TSCO). Here's a look at why both of these stocks are good bets for 2022 and beyond.\nMeta Platforms\nThe case for Meta Platforms is straightforward. The tech stock's valuation is very cheap relative to the company's recent growth. Consider that the Facebook parent's trailing-12-month revenue and net income of $112 billion and $40 billion, respectively, are up from $71 billion and $18 billion in 2019. Even with such staggering recent growth, Meta Platforms trades at only 24 times its current level of earnings.\nWhile the company is running into some near-term growth headwinds related to Apple's recent changes to advertising tracking and measurement, it's not like the suppressed growth Meta Platforms is expecting is poor. Management guided for fourth-quarter revenue to be between $31.5 billion and $34 billion. The midpoint of this guidance range represents 17% revenue growth. Further, analysts are still modeling for exceptional earnings-per-share growth over the next five years. On average, analysts currently expect Meta Platforms' earnings per share to compound at a growth rate of 21% annually over this period.\nMeta Platforms' network effect of billions of monthly active users makes its business very durable. Not only has the company's core Facebook platform consistently grown larger with no close challenger, but the company's other social networks with more intense competition (namely Instagram) have shown they can easily deploy features that imitate successful competitors, helping them stay relevant.\nTractor Supply Company\nSome city folk may have never even stepped foot in a Tractor Supply store. But investors shouldn't overlook this investment just because they're not familiar with the retailer. Tractor Supply, which specializes in rural lifestyle, has a strong retail niche and is capitalizing well on several different important growth catalysts, including private label and exclusive brands, pet food, and e-commerce. Its balanced business has helped revenue grow 24% year over year in the trailing 12 months, and helped earnings per share grow 22%.\nTractor Supply is notably mastering e-commerce in a market where many of its customers live farther apart than people do in the city. These communities come with unique challenges that Tractor Supply is able to develop expertise in, and the company's strategy is working. Tractor Supply said on its most recent earnings call that its e-commerce sales increased at a rate faster than 40% year over year.\nWhile the stock's price-to-earnings ratio of 29 isn't exactly cheap, the company's positioning as the lead retailer for the rural lifestyle makes this business worth paying up for. Given how specialized Tractor Supply is, it would be very difficult for a competitor to topple it. The company also pays a dividend and is regularly repurchasing shares, supplementing shareholder value creation.\nFacebook and Tractor Supply together represent two solid ideas from very different industries that provide meaningful long-term growth potential for investors.","news_type":1},"isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698102549,"gmtCreate":1640312990313,"gmtModify":1640313803964,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698102549","repostId":"2193078140","repostType":4,"repost":{"id":"2193078140","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640299360,"share":"https://www.laohu8.com/m/news/2193078140?lang=&edition=full","pubTime":"2021-12-24 06:42","market":"us","language":"en","title":"S&P 500 hits record close as Omicron fears ebb","url":"https://stock-news.laohu8.com/highlight/detail?id=2193078140","media":"Reuters","summary":"* Major indexes climb for 3rd straight session\n* Merck's at-home COVID-19 pill gets U.S. approval\n* ","content":"<p>* Major indexes climb for 3rd straight session</p>\n<p>* Merck's at-home COVID-19 pill gets U.S. approval</p>\n<p>* Weekly jobless claims unchanged at 205,000</p>\n<p>* Consumer spending increases 0.6% in November</p>\n<p>* Indexes up: Dow 0.55%, S&amp;P 0.62%, Nasdaq 0.85%</p>\n<p>Dec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&amp;P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.</p>\n<p>Stocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&amp;P 500 sectors, led by consumer discretionary&nbsp;and industrials, which both rose about 1.2%.</p>\n<p>Vaccine makers <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a>&nbsp;and Novavax Inc&nbsp;said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.</p>\n<p>The arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.</p>\n<p>“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 196.67 points, or 0.55%, to 35,950.56, the S&amp;P 500&nbsp;gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite&nbsp;added 131.48 points, or 0.85%, to 15,653.37.</p>\n<p>Defensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector&nbsp;fell 0.4%.</p>\n<p>The S&amp;P 500 has gained for three days, after falling in the three prior sessions.</p>\n<p>“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>For the week, the S&amp;P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.</p>\n<p>Trading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.</p>\n<p>In another medical development against the pandemic, the United States authorized Merck &amp; Co's&nbsp;antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.</p>\n<p>The number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.</p>\n<p>Tesla Inc&nbsp;shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.</p>\n<p>The S&amp;P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.</p>\n<p>About 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 hits record close as Omicron fears ebb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 hits record close as Omicron fears ebb\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-24 06:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Major indexes climb for 3rd straight session</p>\n<p>* Merck's at-home COVID-19 pill gets U.S. approval</p>\n<p>* Weekly jobless claims unchanged at 205,000</p>\n<p>* Consumer spending increases 0.6% in November</p>\n<p>* Indexes up: Dow 0.55%, S&amp;P 0.62%, Nasdaq 0.85%</p>\n<p>Dec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&amp;P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.</p>\n<p>Stocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&amp;P 500 sectors, led by consumer discretionary&nbsp;and industrials, which both rose about 1.2%.</p>\n<p>Vaccine makers <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a>&nbsp;and Novavax Inc&nbsp;said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.</p>\n<p>The arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.</p>\n<p>“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 196.67 points, or 0.55%, to 35,950.56, the S&amp;P 500&nbsp;gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite&nbsp;added 131.48 points, or 0.85%, to 15,653.37.</p>\n<p>Defensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector&nbsp;fell 0.4%.</p>\n<p>The S&amp;P 500 has gained for three days, after falling in the three prior sessions.</p>\n<p>“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>For the week, the S&amp;P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.</p>\n<p>Trading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.</p>\n<p>In another medical development against the pandemic, the United States authorized Merck &amp; Co's&nbsp;antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.</p>\n<p>The number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.</p>\n<p>Tesla Inc&nbsp;shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.</p>\n<p>The S&amp;P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.</p>\n<p>About 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SDS":"两倍做空标普500ETF","SH":"标普500反向ETF","OEX":"标普100","SPXU":"三倍做空标普500ETF","UPRO":"三倍做多标普500ETF","SPY":"标普500ETF","BK4534":"瑞士信贷持仓","OEF":"标普100指数ETF-iShares","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","SSO":"两倍做多标普500ETF","IVV":"标普500指数ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","BK4504":"桥水持仓",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193078140","content_text":"* Major indexes climb for 3rd straight session\n* Merck's at-home COVID-19 pill gets U.S. approval\n* Weekly jobless claims unchanged at 205,000\n* Consumer spending increases 0.6% in November\n* Indexes up: Dow 0.55%, S&P 0.62%, Nasdaq 0.85%\nDec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.\nStocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&P 500 sectors, led by consumer discretionary and industrials, which both rose about 1.2%.\nVaccine makers AstraZeneca Plc and Novavax Inc said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.\nThe arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.\n“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.\nThe Dow Jones Industrial Average rose 196.67 points, or 0.55%, to 35,950.56, the S&P 500 gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite added 131.48 points, or 0.85%, to 15,653.37.\nDefensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector fell 0.4%.\nThe S&P 500 has gained for three days, after falling in the three prior sessions.\n“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.\nFor the week, the S&P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.\nTrading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.\nIn another medical development against the pandemic, the United States authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.\nThe number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.\nTesla Inc shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.\nThe S&P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.\nThe S&P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.\nAbout 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698098030,"gmtCreate":1640255617815,"gmtModify":1640255620311,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698098030","repostId":"2193422197","repostType":4,"repost":{"id":"2193422197","pubTimestamp":1640252880,"share":"https://www.laohu8.com/m/news/2193422197?lang=&edition=full","pubTime":"2021-12-23 17:48","market":"us","language":"en","title":"If I Could Only Buy 1 Stock Right Now, This Would Be It","url":"https://stock-news.laohu8.com/highlight/detail?id=2193422197","media":"Motley Fool","summary":"Costco offers solid growth and the prospect of special dividends.","content":"<p>A diversified portfolio helps spread out your risk. That's because you have other stocks to pick up the slack in case <a href=\"https://laohu8.com/S/AONE.U\">one</a> company runs into trouble. However, it's OK to have a favorite. Hence, if you could only buy one stock, it should be the best of the lot.</p>\n<p><b>Costco Wholesale </b>(NASDAQ:COST) has been around for decades, but this isn't a mature, slow-growing company. Let's take a closer look to see what makes Costco so special.</p>\n<h2>A fine business</h2>\n<p>Costco operates large warehouses with a wide variety of goods and services at low prices to its members, who pay a fee to join. In the U.S. and Canada, the basic annual charge is $60. Executive members pay double that amount, but receive a 2% reward on their purchases that they can redeem at the warehouses.</p>\n<p>Members clearly find it worthwhile. Renewal rates have hovered around 90% for years. And Costco keeps adding new members. The number of paid memberships has grown steadily, reaching 61.7 million at the end of the latest fiscal year (ended Aug. 29), up from 53.9 million only a couple of years ago.</p>\n<p>Its loyal members continue to spend as demonstrated by years of same-store sales (comps) growth. In the first quarter, comps -- excluding changes in gasoline prices and foreign currency -- were up 9.8%. That follows a 13.4% gain last year. What's more, the growth has been accelerating. In 2017, comps increased just 4%.</p>\n<p>The company's profitability has been growing at a nice clip too. Operating income in the latest fiscal year totaled $6.7 billion, 63% higher than five years ago. And it continues to improve. Thanks to strong execution in the first quarter, operating income grew by more than 18% to $1.7 billion -- and that's despite dealing with supply chain issues and higher costs plaguing the retail industry.</p>\n<h2>Nice growth outlook</h2>\n<p>This year's capital expenditure budget is over $4 billion, about an 11% increase from last year. Management is spending this mostly on logistics, e-commerce fulfillment operations, and expanding warehouses.</p>\n<p>As of August, Costco had 815 warehouses, an increase of 100 from August 2016. And the company continues to add more, including another eight stores already in the first quarter and 19 more on the way in the next three quarters.</p>\n<p>With stores continuing to do well and e-commerce sales growing rapidly (up 13.3% in the most recent quarter), this should all help Costco's top line growth.</p>\n<h2>Dividends with a kick</h2>\n<p>Costco has raised its dividend annually since initiating it in 2004 and there's every reason to think it will continue to do so. In May, the company increased its quarterly payout by 13% to $0.79 per share. The dividend yield currently stands at a modest 0.6% -- less than half of the <b>S&amp;P 500</b>'s 1.3%.</p>\n<p>However, Costco has made a habit out of declaring large, special dividends every few years. A year ago, it paid out $10 per share and in May 2017 it gave $7. While there's no guarantee it will do so in the future, Costco's increased profitability means it's a good bet that the company will continue this practice.</p>\n<p>Costco has proven it can offer a great value proposition to customers, and its sales and earnings growth don't look likely to stop anytime soon. Meanwhile, the company also provides improving dividends, which it supplements with special payments. It's this combination of growth and dividends that puts Costco at the top of my list of stocks.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>If I Could Only Buy 1 Stock Right Now, This Would Be It</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIf I Could Only Buy 1 Stock Right Now, This Would Be It\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 17:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/22/if-i-could-only-buy-1-stock-right-now-this-would-b/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A diversified portfolio helps spread out your risk. That's because you have other stocks to pick up the slack in case one company runs into trouble. However, it's OK to have a favorite. Hence, if you ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/22/if-i-could-only-buy-1-stock-right-now-this-would-b/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4550":"红杉资本持仓","COST":"好市多","BK4155":"大卖场与超市","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4504":"桥水持仓"},"source_url":"https://www.fool.com/investing/2021/12/22/if-i-could-only-buy-1-stock-right-now-this-would-b/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193422197","content_text":"A diversified portfolio helps spread out your risk. That's because you have other stocks to pick up the slack in case one company runs into trouble. However, it's OK to have a favorite. Hence, if you could only buy one stock, it should be the best of the lot.\nCostco Wholesale (NASDAQ:COST) has been around for decades, but this isn't a mature, slow-growing company. Let's take a closer look to see what makes Costco so special.\nA fine business\nCostco operates large warehouses with a wide variety of goods and services at low prices to its members, who pay a fee to join. In the U.S. and Canada, the basic annual charge is $60. Executive members pay double that amount, but receive a 2% reward on their purchases that they can redeem at the warehouses.\nMembers clearly find it worthwhile. Renewal rates have hovered around 90% for years. And Costco keeps adding new members. The number of paid memberships has grown steadily, reaching 61.7 million at the end of the latest fiscal year (ended Aug. 29), up from 53.9 million only a couple of years ago.\nIts loyal members continue to spend as demonstrated by years of same-store sales (comps) growth. In the first quarter, comps -- excluding changes in gasoline prices and foreign currency -- were up 9.8%. That follows a 13.4% gain last year. What's more, the growth has been accelerating. In 2017, comps increased just 4%.\nThe company's profitability has been growing at a nice clip too. Operating income in the latest fiscal year totaled $6.7 billion, 63% higher than five years ago. And it continues to improve. Thanks to strong execution in the first quarter, operating income grew by more than 18% to $1.7 billion -- and that's despite dealing with supply chain issues and higher costs plaguing the retail industry.\nNice growth outlook\nThis year's capital expenditure budget is over $4 billion, about an 11% increase from last year. Management is spending this mostly on logistics, e-commerce fulfillment operations, and expanding warehouses.\nAs of August, Costco had 815 warehouses, an increase of 100 from August 2016. And the company continues to add more, including another eight stores already in the first quarter and 19 more on the way in the next three quarters.\nWith stores continuing to do well and e-commerce sales growing rapidly (up 13.3% in the most recent quarter), this should all help Costco's top line growth.\nDividends with a kick\nCostco has raised its dividend annually since initiating it in 2004 and there's every reason to think it will continue to do so. In May, the company increased its quarterly payout by 13% to $0.79 per share. The dividend yield currently stands at a modest 0.6% -- less than half of the S&P 500's 1.3%.\nHowever, Costco has made a habit out of declaring large, special dividends every few years. A year ago, it paid out $10 per share and in May 2017 it gave $7. While there's no guarantee it will do so in the future, Costco's increased profitability means it's a good bet that the company will continue this practice.\nCostco has proven it can offer a great value proposition to customers, and its sales and earnings growth don't look likely to stop anytime soon. Meanwhile, the company also provides improving dividends, which it supplements with special payments. It's this combination of growth and dividends that puts Costco at the top of my list of stocks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":304,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691689077,"gmtCreate":1640183609901,"gmtModify":1640183758903,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691689077","repostId":"2193019234","repostType":4,"repost":{"id":"2193019234","pubTimestamp":1640181878,"share":"https://www.laohu8.com/m/news/2193019234?lang=&edition=full","pubTime":"2021-12-22 22:04","market":"us","language":"en","title":"France cancels order for Merck's COVID-19 antiviral drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2193019234","media":"Reuters","summary":"PARIS, Dec 22 (Reuters) - France has cancelled its order for Merck & Co's COVID-19 antiviral drug fo","content":"<p>PARIS, Dec 22 (Reuters) - France has cancelled its order for Merck &amp; Co's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the end of January, the health minister said on Wednesday.</p>\n<p>France is the first country to publicly say it has cancelled an order for the Merck treatment after the company released data in late November suggesting its drug was markedly less effective than previously thought, reducing hospitalisations and deaths in its clinical trial of high-risk individuals by about 30%.</p>\n<p>\"The latest studies weren't good,\" Olivier Veran told BFM TV.</p>\n<p>Merck did not immediately respond to Reuters' request for comment.</p>\n<p>While vaccines are the main weapons against COVID-19 for governments, there are hopes Merck and Pfizer's experimental pills could be a game-changer in reducing the chances of dying or hospitalisation for those most at risk of severe illness.</p>\n<p>France had placed an early order for 50,000 doses of the drug molnupiravir developed by Merck and Ridgeback Biotherapeutics.</p>\n<p>The cancellation would not incur a cost, Veran said.</p>\n<p>In Italy, the office of the special commissioner for the COVID emergency said on Nov 18 it had received a mandate from the health ministry to buy 50,000 courses of Merck's pill and another 50,000 of Pfizer's <a href=\"https://laohu8.com/S/AONE.U\">one</a>. \"The contract has not yet been finalised, but is in progress,\" a spokesperson for the commissioner told Reuters on Tuesday.</p>\n<p>Italian drug regulator Aifa's head Nicola Magrini told a Senate committee on Dec. 9 the two treatments could be available in Italy from the end of January.</p>\n<p>However, regardless of the availability of the drugs, there will be assessments of their use, two top government scientific advisers told Reuters.</p>\n<p>\"There must and will be an evaluation, independently of the assessments of regulatory bodies,\" Walter Ricciardi, top adviser of health minister Roberto Speranza, told Reuters.</p>\n<p>Germany has already bought Merck's antiviral treatment, health minister Karl Lauterbach told Reuters on Wednesday.</p>\n<p>\"This is a binding order,\" he said, adding Berlin was also in talks with Pfizer about buying its antiviral drug.</p>\n<p>The European Medicines Agency is expected to decide whether to approve the Merck and Pfizer pills in the new year.</p>\n<p>Pfizer's Paxlovid has shown near 90% efficacy in preventing COVID-19 hospitalisations and deaths in high-risk patients.</p>\n<p>France had purchased that drug instead, Veran said, without saying how many doses it had secured.</p>\n<p>\"France is lined up to get it before the end of January,\" Veran continued. It has not yet been decided whether the drug would be available over the counter in pharmacies, the minister said.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>France cancels order for Merck's COVID-19 antiviral drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFrance cancels order for Merck's COVID-19 antiviral drug\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 22:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-france-cancels-order-mercks-135238223.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>PARIS, Dec 22 (Reuters) - France has cancelled its order for Merck & Co's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the end...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-france-cancels-order-mercks-135238223.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4559":"巴菲特持仓","PFE":"辉瑞","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓","MRK":"默沙东","BK4516":"特朗普概念","BK4007":"制药"},"source_url":"https://finance.yahoo.com/news/1-france-cancels-order-mercks-135238223.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2193019234","content_text":"PARIS, Dec 22 (Reuters) - France has cancelled its order for Merck & Co's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the end of January, the health minister said on Wednesday.\nFrance is the first country to publicly say it has cancelled an order for the Merck treatment after the company released data in late November suggesting its drug was markedly less effective than previously thought, reducing hospitalisations and deaths in its clinical trial of high-risk individuals by about 30%.\n\"The latest studies weren't good,\" Olivier Veran told BFM TV.\nMerck did not immediately respond to Reuters' request for comment.\nWhile vaccines are the main weapons against COVID-19 for governments, there are hopes Merck and Pfizer's experimental pills could be a game-changer in reducing the chances of dying or hospitalisation for those most at risk of severe illness.\nFrance had placed an early order for 50,000 doses of the drug molnupiravir developed by Merck and Ridgeback Biotherapeutics.\nThe cancellation would not incur a cost, Veran said.\nIn Italy, the office of the special commissioner for the COVID emergency said on Nov 18 it had received a mandate from the health ministry to buy 50,000 courses of Merck's pill and another 50,000 of Pfizer's one. \"The contract has not yet been finalised, but is in progress,\" a spokesperson for the commissioner told Reuters on Tuesday.\nItalian drug regulator Aifa's head Nicola Magrini told a Senate committee on Dec. 9 the two treatments could be available in Italy from the end of January.\nHowever, regardless of the availability of the drugs, there will be assessments of their use, two top government scientific advisers told Reuters.\n\"There must and will be an evaluation, independently of the assessments of regulatory bodies,\" Walter Ricciardi, top adviser of health minister Roberto Speranza, told Reuters.\nGermany has already bought Merck's antiviral treatment, health minister Karl Lauterbach told Reuters on Wednesday.\n\"This is a binding order,\" he said, adding Berlin was also in talks with Pfizer about buying its antiviral drug.\nThe European Medicines Agency is expected to decide whether to approve the Merck and Pfizer pills in the new year.\nPfizer's Paxlovid has shown near 90% efficacy in preventing COVID-19 hospitalisations and deaths in high-risk patients.\nFrance had purchased that drug instead, Veran said, without saying how many doses it had secured.\n\"France is lined up to get it before the end of January,\" Veran continued. It has not yet been decided whether the drug would be available over the counter in pharmacies, the minister said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":364,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693420665,"gmtCreate":1640065903455,"gmtModify":1640065905878,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693420665","repostId":"1155628325","repostType":4,"repost":{"id":"1155628325","pubTimestamp":1640064433,"share":"https://www.laohu8.com/m/news/1155628325?lang=&edition=full","pubTime":"2021-12-21 13:27","market":"us","language":"en","title":"Why Meta Platforms Stock Is Down on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1155628325","media":"Motley Fool","summary":"What happened\nShares of Meta Platforms(NASDAQ:FB)-- until recently known as Facebook -- slipped by a","content":"<p>What happened</p>\n<p>Shares of&nbsp;<b>Meta Platforms</b>(NASDAQ:FB)-- until recently known as Facebook -- slipped by as much as 3.2% Monday morning. As of noon ET, the stock was down by 2.8%.</p>\n<p>The social network company was likely being pulled along by a downdraft in the overall market -- particularly for&nbsp;tech stocks.</p>\n<p>So what</p>\n<p>Major Wall Street indices dipped on Monday as the sell-off that began last week continued. That sell-off appeared to have been triggered largely by the Federal Reserve's recent commentary regarding its expectations for raising benchmark interest rates in 2023. In addition, the rapid spread of the omicron COVID-19 variant across the U.S. and worldwide even as a delta-driven surge is already underway may be spooking some investors.</p>\n<p>The tech-heavy&nbsp;<b>Nasdaq Composite</b>&nbsp;was down by more than 1.6% as of this writing -- a slightly larger decline than the&nbsp;<b>Dow Jones Industrial Average</b>.</p>\n<p>Meta may also be slipping Monday because investment research firm Loop Capital cut its price target on the stock from $420 to $380. That revised price target, though, is more than 17% higher than where the stock was trading at as of midday.</p>\n<p>The tech stock has now fallen by more than 11% over the past three months.</p>\n<p>Now what</p>\n<p>Some may view the recent pressure on Meta stock as creating a good buying opportunity. The company's price-to-earnings ratio of 23 is extremely conservative considering its strong top- and bottom-line growth in 2021, as well as analysts' expectations for robust annualized earnings growth rates in the double-digit percentages over the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Meta Platforms Stock Is Down on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Meta Platforms Stock Is Down on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 13:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/20/why-meta-platforms-stock-is-down-on-monday/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of Meta Platforms(NASDAQ:FB)-- until recently known as Facebook -- slipped by as much as 3.2% Monday morning. As of noon ET, the stock was down by 2.8%.\nThe social network company...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/20/why-meta-platforms-stock-is-down-on-monday/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/12/20/why-meta-platforms-stock-is-down-on-monday/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155628325","content_text":"What happened\nShares of Meta Platforms(NASDAQ:FB)-- until recently known as Facebook -- slipped by as much as 3.2% Monday morning. As of noon ET, the stock was down by 2.8%.\nThe social network company was likely being pulled along by a downdraft in the overall market -- particularly for tech stocks.\nSo what\nMajor Wall Street indices dipped on Monday as the sell-off that began last week continued. That sell-off appeared to have been triggered largely by the Federal Reserve's recent commentary regarding its expectations for raising benchmark interest rates in 2023. In addition, the rapid spread of the omicron COVID-19 variant across the U.S. and worldwide even as a delta-driven surge is already underway may be spooking some investors.\nThe tech-heavy Nasdaq Composite was down by more than 1.6% as of this writing -- a slightly larger decline than the Dow Jones Industrial Average.\nMeta may also be slipping Monday because investment research firm Loop Capital cut its price target on the stock from $420 to $380. That revised price target, though, is more than 17% higher than where the stock was trading at as of midday.\nThe tech stock has now fallen by more than 11% over the past three months.\nNow what\nSome may view the recent pressure on Meta stock as creating a good buying opportunity. The company's price-to-earnings ratio of 23 is extremely conservative considering its strong top- and bottom-line growth in 2021, as well as analysts' expectations for robust annualized earnings growth rates in the double-digit percentages over the next five years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693695114,"gmtCreate":1640011264545,"gmtModify":1640011267283,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693695114","repostId":"1177864811","repostType":4,"repost":{"id":"1177864811","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640009945,"share":"https://www.laohu8.com/m/news/1177864811?lang=&edition=full","pubTime":"2021-12-20 22:19","market":"us","language":"en","title":"Cerner shares rose 1.35% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1177864811","media":"Tiger Newspress","summary":"Cerner shares rose 1.35% in premarket trading.\nOracle(NYSE:ORCL)is expected to announced tomorrow th","content":"<p>Cerner&nbsp;shares&nbsp;rose&nbsp;1.35%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/54973214f9621b28dfe11eb0cf83417c\" tg-width=\"705\" tg-height=\"604\" width=\"100%\" height=\"auto\"></p>\n<p>Oracle(NYSE:ORCL)is expected to announced tomorrow that it agreed to purchase Cerner(NASDAQ:CERN)for mid $90s/share, according to a&nbsp;tweet&nbsp;from CNBC's David Faber.</p>\n<p>The tweet comes after the WSJ reported last week that Oracle was in advanced discussion to buy Cerner in a deal that may be valued at&nbsp;about $30B.&nbsp;The deal is expected to be Oracle's largest ever.</p>\n<p>The deal is expected to be announced today and will value Cerner at about $95/share, according to a&nbsp;WSJ report.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cerner shares rose 1.35% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCerner shares rose 1.35% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-20 22:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Cerner&nbsp;shares&nbsp;rose&nbsp;1.35%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/54973214f9621b28dfe11eb0cf83417c\" tg-width=\"705\" tg-height=\"604\" width=\"100%\" height=\"auto\"></p>\n<p>Oracle(NYSE:ORCL)is expected to announced tomorrow that it agreed to purchase Cerner(NASDAQ:CERN)for mid $90s/share, according to a&nbsp;tweet&nbsp;from CNBC's David Faber.</p>\n<p>The tweet comes after the WSJ reported last week that Oracle was in advanced discussion to buy Cerner in a deal that may be valued at&nbsp;about $30B.&nbsp;The deal is expected to be Oracle's largest ever.</p>\n<p>The deal is expected to be announced today and will value Cerner at about $95/share, according to a&nbsp;WSJ report.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CERN":"美国塞纳","ORCL":"甲骨文"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177864811","content_text":"Cerner shares rose 1.35% in premarket trading.\nOracle(NYSE:ORCL)is expected to announced tomorrow that it agreed to purchase Cerner(NASDAQ:CERN)for mid $90s/share, according to a tweet from CNBC's David Faber.\nThe tweet comes after the WSJ reported last week that Oracle was in advanced discussion to buy Cerner in a deal that may be valued at about $30B. The deal is expected to be Oracle's largest ever.\nThe deal is expected to be announced today and will value Cerner at about $95/share, according to a WSJ report.","news_type":1},"isVote":1,"tweetType":1,"viewCount":163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699731836,"gmtCreate":1639890382240,"gmtModify":1639890384800,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699731836","repostId":"2192976991","repostType":4,"repost":{"id":"2192976991","pubTimestamp":1639880228,"share":"https://www.laohu8.com/m/news/2192976991?lang=&edition=full","pubTime":"2021-12-19 10:17","market":"us","language":"en","title":"5 Top-Ranked Dividend Growth Stocks for 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2192976991","media":"Zacks","summary":"As volatility and uncertainty continue to threaten the bull market going into the New Year, dividend","content":"<p>As volatility and uncertainty continue to threaten the bull market going into the New Year, dividend investing seems to be a better bet. Though it does not offer dramatic price appreciation, the strategy is a major source of consistent income for investors to create wealth when returns from the equity market are at risk.</p>\n<p>Stocks with a strong history of year-over-year dividend growth form a healthy portfolio with a greater scope of capital appreciation as opposed to simple dividend-paying stocks or those that have high yields. We have selected five dividend growth stocks — <b><a href=\"https://laohu8.com/S/BCC\">Boise Cascade L.L.C.</a></b> BCC, <b>J.B. Hunt Transport Services</b> JBHT, <b>Lowe's Companies</b> LOW, <b>Broadcom Inc. </b>AVGO and <b>Carriage Services</b> CSV — that could be compelling picks for your portfolio.</p>\n<h4><b>Why Dividend Growth?</b></h4>\n<p>Stocks that have a strong history of dividend growth belong to mature companies, which are less susceptible to large swings in the market, and thus act as a hedge against economic or political uncertainty as well as stock market volatility. At the same time, these offer downside protection with their consistent increase in payouts.</p>\n<p>Additionally, these stocks have superior fundamentals that make dividend growth a quality and promising investment for the long term. These include a sustainable business model, a long track of profitability, rising cash flows, good liquidity, a strong balance sheet and some value characteristics. Further, a history of strong dividend growth indicates that dividend increase is likely in the future.</p>\n<p>Moreover, a history of dividend growth year over year leads to a healthy portfolio with a greater scope of capital appreciation than simple dividend-paying stocks or those with high yields. Although these stocks do not necessarily have the highest yields, they have outperformed for a longer period than the broader stock market or any other dividend-paying stock.</p>\n<p>As a result, picking dividend growth stocks appears as a winning strategy when some other parameters are also included.</p>\n<p><b>5-Year Historical Dividend Growth greater than zero</b>: This selects stocks with a solid dividend growth history.</p>\n<p><b>5-Year Historical Sales Growth greater than zero</b>: This represents stocks with a strong record of growing revenues.</p>\n<p><b>5-Year Historical EPS Growth greater than zero</b>: This represents stocks with a solid earnings growth history.</p>\n<p><b>Next 3-5 Year EPS Growth Rate greater than zero</b>: This represents the rate at which a company’s earnings are expected to grow. Improving earnings should help companies sustain dividend payments.</p>\n<p><b>Price/Cash Flow less than M-Industry</b>: A ratio less than M-industry indicates that the stock is undervalued in that industry and that an investor needs to pay less for better cash flow generated by the company.</p>\n<p><b>52-Week Price Change greater than S&amp;P 500 (Market Weight)</b>: This ensures that the stock appreciated more than the S&amp;P 500 over the past year.</p>\n<p><b>Top Zacks Rank</b>: Stocks having a Zacks Rank #1 (Strong Buy) and 2 (Buy) generally outperform their peers in all types of market environments.</p>\n<p><b>Growth Score of B or better</b>: Our research shows that stocks with a Growth Score of A or B when combined with a Zacks Rank #1 or 2 offer the best upside potential.</p>\n<p>Just these few criteria narrowed down the universe from over 7,700 stocks to just 16.</p>\n<p>Here are five of the 16 stocks that fit the bill:</p>\n<p>Idaho-based <b>Boise Cascade</b> operates as a wood products manufacturer and building materials distributor. It has seen solid earnings estimate revision of 13 cents for this year over the past month and has an estimated earnings growth rate of 159%.</p>\n<p>Boise Cascade has a Zacks Rank #1 and Growth Score of A. You can see <b>the complete list of today’s Zacks #1 Rank stocks here</b>.</p>\n<p>Arkansas-based <b>J.B. Hunt Transport </b>is a provider of a broad range of transportation services to a diverse group of customers through the United States, Canada and Mexico. JBHT has an estimated earnings growth rate of 44.5% for this year and delivered an average earnings surprise of 9.89% for the past four quarters.</p>\n<p>J.B. Hunt has a Zacks Rank #2 and Growth Score of A.</p>\n<p>North Carolina-based <b>Lowe's</b> has evolved as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the world’s leading home improvement retailers offering services to homeowners, renters and commercial business customers. LOW saw solid earnings estimate revision of 54 cents over the past 30 days for the fiscal year (ending January 2022) and has an expected earnings growth rate of 34.4%.</p>\n<p>Lowe’s has a Zacks Rank #2 and Growth Score of B.</p>\n<p>California-based <b>Broadcom</b> is a premier designer, developer and global supplier of a broad range of semiconductor devices with a focus on complex digital and mixed-signal complementary metal oxide semiconductor based devices and analog III-V based products. The stock saw a solid earnings estimate revision of $2.01 for the fiscal year (ending October 2022) over the past 30 days and has an expected earnings growth rate of 17.9%.</p>\n<p>Broadcom has a Zacks Rank #2 and Growth Score of B.</p>\n<p>Texas-based <b>Carriage Services</b> is a leading provider of death care services and products in the United States. CSV delivered an average earnings surprise of 27.96% for the past four quarters and has an expected earnings growth rate of 64%.</p>\n<p>Carriage Services carries a Zacks Rank #2 and has a Growth Score of B.</p>\n<p>You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.</p>\n<p>The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top-Ranked Dividend Growth Stocks for 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top-Ranked Dividend Growth Stocks for 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 10:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/5-top-ranked-dividend-growth-133601757.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As volatility and uncertainty continue to threaten the bull market going into the New Year, dividend investing seems to be a better bet. Though it does not offer dramatic price appreciation, the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/5-top-ranked-dividend-growth-133601757.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4520":"美国基建股","BK4083":"家庭装潢零售","CSV":"Carriage Services Inc","BK4104":"贸易公司与经销商","BK4022":"陆运","BK4566":"资本集团","JBHT":"JB Hunt运输服务","BK4515":"5G概念","AVGOP":"BROADCOM INC PFD SER A 22","AVGO":"博通","BK4512":"苹果概念","BK4504":"桥水持仓","LOW":"劳氏","BCC":"Boise Cascade L.L.C.","BK4192":"特殊消费者服务"},"source_url":"https://finance.yahoo.com/news/5-top-ranked-dividend-growth-133601757.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2192976991","content_text":"As volatility and uncertainty continue to threaten the bull market going into the New Year, dividend investing seems to be a better bet. Though it does not offer dramatic price appreciation, the strategy is a major source of consistent income for investors to create wealth when returns from the equity market are at risk.\nStocks with a strong history of year-over-year dividend growth form a healthy portfolio with a greater scope of capital appreciation as opposed to simple dividend-paying stocks or those that have high yields. We have selected five dividend growth stocks — Boise Cascade L.L.C. BCC, J.B. Hunt Transport Services JBHT, Lowe's Companies LOW, Broadcom Inc. AVGO and Carriage Services CSV — that could be compelling picks for your portfolio.\nWhy Dividend Growth?\nStocks that have a strong history of dividend growth belong to mature companies, which are less susceptible to large swings in the market, and thus act as a hedge against economic or political uncertainty as well as stock market volatility. At the same time, these offer downside protection with their consistent increase in payouts.\nAdditionally, these stocks have superior fundamentals that make dividend growth a quality and promising investment for the long term. These include a sustainable business model, a long track of profitability, rising cash flows, good liquidity, a strong balance sheet and some value characteristics. Further, a history of strong dividend growth indicates that dividend increase is likely in the future.\nMoreover, a history of dividend growth year over year leads to a healthy portfolio with a greater scope of capital appreciation than simple dividend-paying stocks or those with high yields. Although these stocks do not necessarily have the highest yields, they have outperformed for a longer period than the broader stock market or any other dividend-paying stock.\nAs a result, picking dividend growth stocks appears as a winning strategy when some other parameters are also included.\n5-Year Historical Dividend Growth greater than zero: This selects stocks with a solid dividend growth history.\n5-Year Historical Sales Growth greater than zero: This represents stocks with a strong record of growing revenues.\n5-Year Historical EPS Growth greater than zero: This represents stocks with a solid earnings growth history.\nNext 3-5 Year EPS Growth Rate greater than zero: This represents the rate at which a company’s earnings are expected to grow. Improving earnings should help companies sustain dividend payments.\nPrice/Cash Flow less than M-Industry: A ratio less than M-industry indicates that the stock is undervalued in that industry and that an investor needs to pay less for better cash flow generated by the company.\n52-Week Price Change greater than S&P 500 (Market Weight): This ensures that the stock appreciated more than the S&P 500 over the past year.\nTop Zacks Rank: Stocks having a Zacks Rank #1 (Strong Buy) and 2 (Buy) generally outperform their peers in all types of market environments.\nGrowth Score of B or better: Our research shows that stocks with a Growth Score of A or B when combined with a Zacks Rank #1 or 2 offer the best upside potential.\nJust these few criteria narrowed down the universe from over 7,700 stocks to just 16.\nHere are five of the 16 stocks that fit the bill:\nIdaho-based Boise Cascade operates as a wood products manufacturer and building materials distributor. It has seen solid earnings estimate revision of 13 cents for this year over the past month and has an estimated earnings growth rate of 159%.\nBoise Cascade has a Zacks Rank #1 and Growth Score of A. You can see the complete list of today’s Zacks #1 Rank stocks here.\nArkansas-based J.B. Hunt Transport is a provider of a broad range of transportation services to a diverse group of customers through the United States, Canada and Mexico. JBHT has an estimated earnings growth rate of 44.5% for this year and delivered an average earnings surprise of 9.89% for the past four quarters.\nJ.B. Hunt has a Zacks Rank #2 and Growth Score of A.\nNorth Carolina-based Lowe's has evolved as one of the world’s leading home improvement retailers offering services to homeowners, renters and commercial business customers. LOW saw solid earnings estimate revision of 54 cents over the past 30 days for the fiscal year (ending January 2022) and has an expected earnings growth rate of 34.4%.\nLowe’s has a Zacks Rank #2 and Growth Score of B.\nCalifornia-based Broadcom is a premier designer, developer and global supplier of a broad range of semiconductor devices with a focus on complex digital and mixed-signal complementary metal oxide semiconductor based devices and analog III-V based products. The stock saw a solid earnings estimate revision of $2.01 for the fiscal year (ending October 2022) over the past 30 days and has an expected earnings growth rate of 17.9%.\nBroadcom has a Zacks Rank #2 and Growth Score of B.\nTexas-based Carriage Services is a leading provider of death care services and products in the United States. CSV delivered an average earnings surprise of 27.96% for the past four quarters and has an expected earnings growth rate of 64%.\nCarriage Services carries a Zacks Rank #2 and has a Growth Score of B.\nYou can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.\nThe Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.","news_type":1},"isVote":1,"tweetType":1,"viewCount":257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699612608,"gmtCreate":1639791240785,"gmtModify":1639791308119,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/699612608","repostId":"1155244596","repostType":4,"repost":{"id":"1155244596","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639752003,"share":"https://www.laohu8.com/m/news/1155244596?lang=&edition=full","pubTime":"2021-12-17 22:40","market":"us","language":"en","title":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list","url":"https://stock-news.laohu8.com/highlight/detail?id=1155244596","media":"Tiger Newspress","summary":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emerg","content":"<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155244596","content_text":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list.The World Health Organization has included its vaccine NVX-CoV2373 on the emergency use list,and its original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.","news_type":1},"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690145193,"gmtCreate":1639649900382,"gmtModify":1639649902829,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Is the economy getting better or worse","listText":"Is the economy getting better or worse","text":"Is the economy getting better or worse","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690145193","isVote":1,"tweetType":1,"viewCount":155,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690099398,"gmtCreate":1639611577289,"gmtModify":1639611579710,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690099398","repostId":"1117099747","repostType":4,"repost":{"id":"1117099747","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639610664,"share":"https://www.laohu8.com/m/news/1117099747?lang=&edition=full","pubTime":"2021-12-16 07:24","market":"us","language":"en","title":"Bad Omen For Tesla? Here's What Happened To Amazon Stock After Jeff Bezos Was Time's 'Person Of The Year'","url":"https://stock-news.laohu8.com/highlight/detail?id=1117099747","media":"Benzinga","summary":"Controversial and influential Tesla Inc CEO Elon Muskwas recently named Time Magazine’s \"Person of t","content":"<p>Controversial and influential&nbsp;<b>Tesla Inc</b>&nbsp;<b>CEO Elon Musk</b>was recently named&nbsp;<b>Time Magazine’s \"Person of the Year\" for 2021</b>. The award is a tremendous honor for Musk, but some long-time&nbsp;<b>Amazon.com, Inc.</b>&nbsp;investors may still have nightmares about the time Amazon founder and former CEO&nbsp;<b>Jeff Bezos</b>&nbsp;was also named Time’s \"Person of the Year.\"</p>\n<p><b>Time Magazine Curse?</b>Bezos received \"Person of the Year\" honors for 1999 on Dec. 20, 1999. On that day, Amazon shares closed at $97. Less than two years later, Amazon shares closed at a new all-time low of $5.67 on Sept. 27, 2001.<b>During that 11-month stretch immediately following Bezos’ award, Amazon shares lost an incredible 94% of their value.</b></p>\n<p>Bezos and Musk have had a somewhat contentious rivalry over the years. Musk and Bezos are also currently the two most wealthy people in the world, worth a combined $437 billion.</p>\n<p>Tesla investors are hoping Tesla shares can avoid the same Time Magazine curse that hit Amazon stock back in 1999. So far, they have not. Musk was announced as \"Person of the Year\" on Monday, and Tesla shares are now down 7.6% since last Friday’s close.</p>\n<p><b>Tesla Risk:</b>Former hedge fund manager Whitney Tilson said Wednesday&nbsp;he does not expect Tesla to repeat Amazon’s 94% Time Magazine sell-off, and he would not recommend traders short Tesla stock.</p>\n<p>“But I will say this: as I scan the 100 companies with the largest market caps that trade in the U.S., Tesla jumps out at me as the one that could cost investors the most money, the fastest…” Tilson said.</p>\n<p><b>Benzinga’s Take:</b>The silver lining for Amazon investors that held on through the bursting of the dot-com bubble is Amazon’s stock has been a more than 600-bagger since it bottomed in 2001. In addition, the stocks of&nbsp;other billionaire tech CEOs have fared much better following \"Person of the Year\" honors. In the two years after Bill Gates was named Time \"Person of the Year\" in 2005,<b>Microsoft Corporation</b>&nbsp;stock was up 31.3%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bad Omen For Tesla? Here's What Happened To Amazon Stock After Jeff Bezos Was Time's 'Person Of The Year'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBad Omen For Tesla? Here's What Happened To Amazon Stock After Jeff Bezos Was Time's 'Person Of The Year'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-16 07:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Controversial and influential&nbsp;<b>Tesla Inc</b>&nbsp;<b>CEO Elon Musk</b>was recently named&nbsp;<b>Time Magazine’s \"Person of the Year\" for 2021</b>. The award is a tremendous honor for Musk, but some long-time&nbsp;<b>Amazon.com, Inc.</b>&nbsp;investors may still have nightmares about the time Amazon founder and former CEO&nbsp;<b>Jeff Bezos</b>&nbsp;was also named Time’s \"Person of the Year.\"</p>\n<p><b>Time Magazine Curse?</b>Bezos received \"Person of the Year\" honors for 1999 on Dec. 20, 1999. On that day, Amazon shares closed at $97. Less than two years later, Amazon shares closed at a new all-time low of $5.67 on Sept. 27, 2001.<b>During that 11-month stretch immediately following Bezos’ award, Amazon shares lost an incredible 94% of their value.</b></p>\n<p>Bezos and Musk have had a somewhat contentious rivalry over the years. Musk and Bezos are also currently the two most wealthy people in the world, worth a combined $437 billion.</p>\n<p>Tesla investors are hoping Tesla shares can avoid the same Time Magazine curse that hit Amazon stock back in 1999. So far, they have not. Musk was announced as \"Person of the Year\" on Monday, and Tesla shares are now down 7.6% since last Friday’s close.</p>\n<p><b>Tesla Risk:</b>Former hedge fund manager Whitney Tilson said Wednesday&nbsp;he does not expect Tesla to repeat Amazon’s 94% Time Magazine sell-off, and he would not recommend traders short Tesla stock.</p>\n<p>“But I will say this: as I scan the 100 companies with the largest market caps that trade in the U.S., Tesla jumps out at me as the one that could cost investors the most money, the fastest…” Tilson said.</p>\n<p><b>Benzinga’s Take:</b>The silver lining for Amazon investors that held on through the bursting of the dot-com bubble is Amazon’s stock has been a more than 600-bagger since it bottomed in 2001. In addition, the stocks of&nbsp;other billionaire tech CEOs have fared much better following \"Person of the Year\" honors. In the two years after Bill Gates was named Time \"Person of the Year\" in 2005,<b>Microsoft Corporation</b>&nbsp;stock was up 31.3%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117099747","content_text":"Controversial and influential Tesla Inc CEO Elon Muskwas recently named Time Magazine’s \"Person of the Year\" for 2021. The award is a tremendous honor for Musk, but some long-time Amazon.com, Inc. investors may still have nightmares about the time Amazon founder and former CEO Jeff Bezos was also named Time’s \"Person of the Year.\"\nTime Magazine Curse?Bezos received \"Person of the Year\" honors for 1999 on Dec. 20, 1999. On that day, Amazon shares closed at $97. Less than two years later, Amazon shares closed at a new all-time low of $5.67 on Sept. 27, 2001.During that 11-month stretch immediately following Bezos’ award, Amazon shares lost an incredible 94% of their value.\nBezos and Musk have had a somewhat contentious rivalry over the years. Musk and Bezos are also currently the two most wealthy people in the world, worth a combined $437 billion.\nTesla investors are hoping Tesla shares can avoid the same Time Magazine curse that hit Amazon stock back in 1999. So far, they have not. Musk was announced as \"Person of the Year\" on Monday, and Tesla shares are now down 7.6% since last Friday’s close.\nTesla Risk:Former hedge fund manager Whitney Tilson said Wednesday he does not expect Tesla to repeat Amazon’s 94% Time Magazine sell-off, and he would not recommend traders short Tesla stock.\n“But I will say this: as I scan the 100 companies with the largest market caps that trade in the U.S., Tesla jumps out at me as the one that could cost investors the most money, the fastest…” Tilson said.\nBenzinga’s Take:The silver lining for Amazon investors that held on through the bursting of the dot-com bubble is Amazon’s stock has been a more than 600-bagger since it bottomed in 2001. In addition, the stocks of other billionaire tech CEOs have fared much better following \"Person of the Year\" honors. In the two years after Bill Gates was named Time \"Person of the Year\" in 2005,Microsoft Corporation stock was up 31.3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":825673820,"gmtCreate":1634224278691,"gmtModify":1634224279511,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Li","listText":"Li","text":"Li","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/825673820","repostId":"1158193238","repostType":4,"repost":{"id":"1158193238","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1634223966,"share":"https://www.laohu8.com/m/news/1158193238?lang=&edition=full","pubTime":"2021-10-14 23:06","market":"us","language":"en","title":"LinkedIn to replace networking platform with jobs-only version in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1158193238","media":"Reuters","summary":"Oct 14 (Reuters) - Microsoft Corp's LinkedIn said on Thursday it would pull the plug on its existing","content":"<p>Oct 14 (Reuters) - Microsoft Corp's&nbsp;LinkedIn said on Thursday it would pull the plug on its existing professional networking website in China and instead launch a jobs-only version later this year.</p>\n<p>The new website, called InJobs, will not include a social feed or the ability to share posts or articles, LinkedIn said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LinkedIn to replace networking platform with jobs-only version in China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLinkedIn to replace networking platform with jobs-only version in China\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-14 23:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Oct 14 (Reuters) - Microsoft Corp's&nbsp;LinkedIn said on Thursday it would pull the plug on its existing professional networking website in China and instead launch a jobs-only version later this year.</p>\n<p>The new website, called InJobs, will not include a social feed or the ability to share posts or articles, LinkedIn said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158193238","content_text":"Oct 14 (Reuters) - Microsoft Corp's LinkedIn said on Thursday it would pull the plug on its existing professional networking website in China and instead launch a jobs-only version later this year.\nThe new website, called InJobs, will not include a social feed or the ability to share posts or articles, LinkedIn said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":77,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866697909,"gmtCreate":1632759285601,"gmtModify":1632798019094,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Li","listText":"Li","text":"Li","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/866697909","repostId":"1143307489","repostType":4,"repost":{"id":"1143307489","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632757396,"share":"https://www.laohu8.com/m/news/1143307489?lang=&edition=full","pubTime":"2021-09-27 23:43","market":"us","language":"en","title":"Cannabis stocks jumped in Monday morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1143307489","media":"Tiger Newspress","summary":"Cannabis stocks jumped in Monday morning trading as U.S. House approved bill to ease banking for can","content":"<p>Cannabis stocks jumped in Monday morning trading&nbsp;as&nbsp;U.S. House approved bill to ease banking for cannabis companies.Canopy Growth,Tilray, Aurora Cannabis, Cronos, Sundial Growers&nbsp;and&nbsp;OrganiGram&nbsp;climbed between 2% and 6%.</p>\n<p><img src=\"https://static.tigerbbs.com/b7d7c6db300ed6a9e7a2699a1884e853\" tg-width=\"399\" tg-height=\"417\" referrerpolicy=\"no-referrer\"></p>\n<p>The U.S. House of Representatives late last&nbsp;Tuesday night approved a bill that would let banks to do business with cannabis companies without fear of penalty, giving traction to the least-disputed reform sought by the growing industry.</p>\n<p>The so-called SAFE Banking Act, which is the least disputed reform sought by the growing industry, got picked up as part of broader legislation, and its inclusion in the National Defense Authorization Act was approved by voice vote late Tuesday. It remains to be seen whether the bill will pass the Senate, but the House action gives it a better shot.</p>\n<p>The act would be a boon for marijuana companies, which have so far been stymied by the need to deal in cash because of federal restrictions. That has meant they have extra security costs and logistical problems, even as marijuana increasingly becomes legal. Some three dozen states now allow medical or recreational use, according to New Frontier Data, a cannabis research firm.</p>\n<p><img src=\"https://static.tigerbbs.com/94634a1c93ee67a96440d95391009461\" tg-width=\"748\" tg-height=\"663\" referrerpolicy=\"no-referrer\"></p>\n<p>Representative Ed Perlmutter, a Colorado Democrat, who had re-introduced the bill,has said&nbsp;that allowing cannabis businesses to access the banking system would bring more money into the economy and offer the opportunity to create good-paying jobs. The American cannabis industry had $20.3 billion in legal sales in 2020, according New Frontier Data.</p>\n<p>The initiative, which has been passed by the House before with bipartisan support but never advanced to the Senate, is still a far cry from the wish list of legal reforms sought by the industry, which include all-out legalization and relief from tax burdens.</p>\n<p>The U.S. Cannabis Council, a trade group, called the current rules that require marijuana firms to be all-cash a security hazard.</p>\n<p>“Over $17 billion in legal cannabis was sold in the United States last year, overwhelmingly through cash transactions. Forcing legitimate, well-regulated cannabis businesses to conduct most of their business in cash is anachronistic and a clear threat to public safety,” the council’s chief executive officer, Steven Hawkins, said in a statement before the bill passed.</p>\n<p>“Every step forward is a positive one for the cannabis industry,”BTIGanalyst Camilo Lyon said in a research note Wednesday. He said it isn’t clear whether Senator Chuck Schumer will include the act in the Senate NDAA bill.</p>\n<p>“Discussions with our D.C. contacts suggest it has an easier pathway of getting through the Senate, largely because no senator wants to be viewed as holding up the massive 1,700 page must-pass NDAA simply because of SAFE banking,” Lyon wrote.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cannabis stocks jumped in Monday morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCannabis stocks jumped in Monday morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-27 23:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Cannabis stocks jumped in Monday morning trading&nbsp;as&nbsp;U.S. House approved bill to ease banking for cannabis companies.Canopy Growth,Tilray, Aurora Cannabis, Cronos, Sundial Growers&nbsp;and&nbsp;OrganiGram&nbsp;climbed between 2% and 6%.</p>\n<p><img src=\"https://static.tigerbbs.com/b7d7c6db300ed6a9e7a2699a1884e853\" tg-width=\"399\" tg-height=\"417\" referrerpolicy=\"no-referrer\"></p>\n<p>The U.S. House of Representatives late last&nbsp;Tuesday night approved a bill that would let banks to do business with cannabis companies without fear of penalty, giving traction to the least-disputed reform sought by the growing industry.</p>\n<p>The so-called SAFE Banking Act, which is the least disputed reform sought by the growing industry, got picked up as part of broader legislation, and its inclusion in the National Defense Authorization Act was approved by voice vote late Tuesday. It remains to be seen whether the bill will pass the Senate, but the House action gives it a better shot.</p>\n<p>The act would be a boon for marijuana companies, which have so far been stymied by the need to deal in cash because of federal restrictions. That has meant they have extra security costs and logistical problems, even as marijuana increasingly becomes legal. Some three dozen states now allow medical or recreational use, according to New Frontier Data, a cannabis research firm.</p>\n<p><img src=\"https://static.tigerbbs.com/94634a1c93ee67a96440d95391009461\" tg-width=\"748\" tg-height=\"663\" referrerpolicy=\"no-referrer\"></p>\n<p>Representative Ed Perlmutter, a Colorado Democrat, who had re-introduced the bill,has said&nbsp;that allowing cannabis businesses to access the banking system would bring more money into the economy and offer the opportunity to create good-paying jobs. The American cannabis industry had $20.3 billion in legal sales in 2020, according New Frontier Data.</p>\n<p>The initiative, which has been passed by the House before with bipartisan support but never advanced to the Senate, is still a far cry from the wish list of legal reforms sought by the industry, which include all-out legalization and relief from tax burdens.</p>\n<p>The U.S. Cannabis Council, a trade group, called the current rules that require marijuana firms to be all-cash a security hazard.</p>\n<p>“Over $17 billion in legal cannabis was sold in the United States last year, overwhelmingly through cash transactions. Forcing legitimate, well-regulated cannabis businesses to conduct most of their business in cash is anachronistic and a clear threat to public safety,” the council’s chief executive officer, Steven Hawkins, said in a statement before the bill passed.</p>\n<p>“Every step forward is a positive one for the cannabis industry,”BTIGanalyst Camilo Lyon said in a research note Wednesday. He said it isn’t clear whether Senator Chuck Schumer will include the act in the Senate NDAA bill.</p>\n<p>“Discussions with our D.C. contacts suggest it has an easier pathway of getting through the Senate, largely because no senator wants to be viewed as holding up the massive 1,700 page must-pass NDAA simply because of SAFE banking,” Lyon wrote.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","OGI":"ORGANIGRAM HOLD","TLRY":"Tilray Inc.","ACB":"奥罗拉大麻公司","SNDL":"SNDL Inc.","CRON":"Cronos Group Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143307489","content_text":"Cannabis stocks jumped in Monday morning trading as U.S. House approved bill to ease banking for cannabis companies.Canopy Growth,Tilray, Aurora Cannabis, Cronos, Sundial Growers and OrganiGram climbed between 2% and 6%.\n\nThe U.S. House of Representatives late last Tuesday night approved a bill that would let banks to do business with cannabis companies without fear of penalty, giving traction to the least-disputed reform sought by the growing industry.\nThe so-called SAFE Banking Act, which is the least disputed reform sought by the growing industry, got picked up as part of broader legislation, and its inclusion in the National Defense Authorization Act was approved by voice vote late Tuesday. It remains to be seen whether the bill will pass the Senate, but the House action gives it a better shot.\nThe act would be a boon for marijuana companies, which have so far been stymied by the need to deal in cash because of federal restrictions. That has meant they have extra security costs and logistical problems, even as marijuana increasingly becomes legal. Some three dozen states now allow medical or recreational use, according to New Frontier Data, a cannabis research firm.\n\nRepresentative Ed Perlmutter, a Colorado Democrat, who had re-introduced the bill,has said that allowing cannabis businesses to access the banking system would bring more money into the economy and offer the opportunity to create good-paying jobs. The American cannabis industry had $20.3 billion in legal sales in 2020, according New Frontier Data.\nThe initiative, which has been passed by the House before with bipartisan support but never advanced to the Senate, is still a far cry from the wish list of legal reforms sought by the industry, which include all-out legalization and relief from tax burdens.\nThe U.S. Cannabis Council, a trade group, called the current rules that require marijuana firms to be all-cash a security hazard.\n“Over $17 billion in legal cannabis was sold in the United States last year, overwhelmingly through cash transactions. Forcing legitimate, well-regulated cannabis businesses to conduct most of their business in cash is anachronistic and a clear threat to public safety,” the council’s chief executive officer, Steven Hawkins, said in a statement before the bill passed.\n“Every step forward is a positive one for the cannabis industry,”BTIGanalyst Camilo Lyon said in a research note Wednesday. He said it isn’t clear whether Senator Chuck Schumer will include the act in the Senate NDAA bill.\n“Discussions with our D.C. contacts suggest it has an easier pathway of getting through the Senate, largely because no senator wants to be viewed as holding up the massive 1,700 page must-pass NDAA simply because of SAFE banking,” Lyon wrote.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842070641,"gmtCreate":1636122557014,"gmtModify":1636122560513,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PROG\">$Progenity, Inc.(PROG)$</a>&nbsp;too many short list","listText":"<a href=\"https://laohu8.com/S/PROG\">$Progenity, Inc.(PROG)$</a>&nbsp;too many short list","text":"$Progenity, Inc.(PROG)$ too many short list","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/842070641","isVote":1,"tweetType":1,"viewCount":1176,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841283648,"gmtCreate":1635914841995,"gmtModify":1635914842953,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Li","listText":"Li","text":"Li","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/841283648","repostId":"2180782003","repostType":4,"repost":{"id":"2180782003","pubTimestamp":1635910680,"share":"https://www.laohu8.com/m/news/2180782003?lang=&edition=full","pubTime":"2021-11-03 11:38","market":"us","language":"en","title":"1 Red-Hot Semiconductor Stock That Just Crushed Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2180782003","media":"Motley Fool","summary":"Despite overwhelming strength in semiconductor stocks this year, Cohu still presents great value.","content":"<p>Semiconductor shortages have dominated headlines in the business world this year. Manufacturers of consumer goods across the globe are struggling to meet their production targets because they can't get their hands on enough computer chips.</p>\n<p>New cars are <a href=\"https://laohu8.com/S/AONE.U\">one</a> enormous source of demand for semiconductors, especially with the growth of electric vehicles, and dealer lots are currently running on a fraction of the inventory they need to meet demand.</p>\n<p>The issue has pushed consumers into the used car market, sending prices soaring 24.4% on average over the last 12 months. But semiconductor-service powerhouse <b>Cohu </b>(NASDAQ:COHU) is helping to alleviate these supply pressures, and it just delivered another big quarterly result. Here's how.</p>\n<h2>Automotive chips continue driving Cohu forward</h2>\n<p>Cohu provides testing and handling equipment to the world's largest semiconductor producers, assisting in the manufacture of computer chips for a range of applications including consumer electronics, mobility, and even the automotive market.</p>\n<p>That segment has grown to become the company's largest, accounting for 20% of total revenue in the third quarter just announced, up from 18% in the second quarter. It highlights persistent demand from semiconductor producers that need to expand manufacturing capacity in preparation for a future consisting of smarter, more feature-heavy vehicles.</p>\n<p>But it also displays Cohu's clever strategic focus, pivoting its attention to where it's needed most right now, which is helping producers clear order backlogs and relieve shortages.</p>\n<p>Its Neon inspection and high-speed handling systems are designed to rapidly inspect computer chips as small as 0.2 millimeters by 0.4 millimeters, which are often used in automotive applications. These fragile components require delicate yet fast handling, so defects can be detected in efficient time frames so as not to hold up the production process.</p>\n<p>Cohu's portfolio of automotive-related semiconductor equipment also extends to real-world-style environmental testing to ensure chips can withstand the stresses of everyday use. It also offers the capability to test and handle chips for new technologies like autonomous driving and broad electrification, which should play a significant role in the future of the automotive industry.</p>\n<h2>Strong third-quarter results</h2>\n<p>Cohu delivered 49% year-over-year revenue growth and 159% year-over-year earnings per share growth in the third quarter. Its $0.70 in third-quarter EPS adds to what is expected to be the company's first profitable year since 2017, after spending several years investing in the business.</p>\n<p>Overall, as the end of the year approaches, 2021 financial results are set to crush what Cohu delivered in 2020.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>2020</p></th>\n   <th><p>2021 (Estimate)</p></th>\n   <th><p>Growth</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td><p>Revenue</p></td>\n   <td><p>$636 million</p></td>\n   <td><p>$902 million</p></td>\n   <td><p>41%</p></td>\n  </tr>\n  <tr>\n   <td><p>EPS (Loss)</p></td>\n   <td><p>($0.33)</p></td>\n   <td><p>$3.05</p></td>\n   <td><p>N/A</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Cohu, Yahoo! Finance.</p>\n<p>The company's 41% estimated revenue growth would more than quadruple the 9% it generated in 2020 (when compared to 2019).</p>\n<p>Cohu is so comfortable with its financial position right now that it just announced a $70 million share buyback program to return money to shareholders. It's not something investors would typically see from a relatively small $1.5 billion growth company, but it's an added benefit to the 47% rise in share price over the last 12 months.</p>\n<h2>Why you should buy the stock</h2>\n<p>When it comes to semiconductor stocks, many of them have experienced red-hot share price growth lately as investors price in higher profits from rising demand and low supply. Regardless, Cohu remains incredibly cheap compared to its peers.</p>\n<p>The <b><a href=\"https://laohu8.com/S/EEME\">iShares</a> Semiconductor ETF </b>trades at a price-to-earnings multiple of 33, compared to a multiple of less than 11 for Cohu based on $3.05 in 2021 EPS. That means the stock would need to triple to align with the broader industry on a valuation basis.</p>\n<p>Analysts expect Cohu to be just as profitable in 2022, so investors shouldn't be concerned that 2021 was a one-off result following a few years of losses. It aligns with the broader sentiment among car manufacturers, which suggests semiconductor shortages will persist well into the new year. That will only mean one thing: Demand for Cohu's testing and handling equipment is likely to remain elevated.</p>\n<p>Cohu's strong third quarter is just another piece in its overwhelmingly positive story. Wall Street is certainly on board, with one firm predicting the stock will more than double from here.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>1 Red-Hot Semiconductor Stock That Just Crushed Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n1 Red-Hot Semiconductor Stock That Just Crushed Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-03 11:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/02/1-semiconductor-stock-that-just-crushed-earnings/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Semiconductor shortages have dominated headlines in the business world this year. Manufacturers of consumer goods across the globe are struggling to meet their production targets because they can't ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/02/1-semiconductor-stock-that-just-crushed-earnings/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COHU":"科休半导体"},"source_url":"https://www.fool.com/investing/2021/11/02/1-semiconductor-stock-that-just-crushed-earnings/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2180782003","content_text":"Semiconductor shortages have dominated headlines in the business world this year. Manufacturers of consumer goods across the globe are struggling to meet their production targets because they can't get their hands on enough computer chips.\nNew cars are one enormous source of demand for semiconductors, especially with the growth of electric vehicles, and dealer lots are currently running on a fraction of the inventory they need to meet demand.\nThe issue has pushed consumers into the used car market, sending prices soaring 24.4% on average over the last 12 months. But semiconductor-service powerhouse Cohu (NASDAQ:COHU) is helping to alleviate these supply pressures, and it just delivered another big quarterly result. Here's how.\nAutomotive chips continue driving Cohu forward\nCohu provides testing and handling equipment to the world's largest semiconductor producers, assisting in the manufacture of computer chips for a range of applications including consumer electronics, mobility, and even the automotive market.\nThat segment has grown to become the company's largest, accounting for 20% of total revenue in the third quarter just announced, up from 18% in the second quarter. It highlights persistent demand from semiconductor producers that need to expand manufacturing capacity in preparation for a future consisting of smarter, more feature-heavy vehicles.\nBut it also displays Cohu's clever strategic focus, pivoting its attention to where it's needed most right now, which is helping producers clear order backlogs and relieve shortages.\nIts Neon inspection and high-speed handling systems are designed to rapidly inspect computer chips as small as 0.2 millimeters by 0.4 millimeters, which are often used in automotive applications. These fragile components require delicate yet fast handling, so defects can be detected in efficient time frames so as not to hold up the production process.\nCohu's portfolio of automotive-related semiconductor equipment also extends to real-world-style environmental testing to ensure chips can withstand the stresses of everyday use. It also offers the capability to test and handle chips for new technologies like autonomous driving and broad electrification, which should play a significant role in the future of the automotive industry.\nStrong third-quarter results\nCohu delivered 49% year-over-year revenue growth and 159% year-over-year earnings per share growth in the third quarter. Its $0.70 in third-quarter EPS adds to what is expected to be the company's first profitable year since 2017, after spending several years investing in the business.\nOverall, as the end of the year approaches, 2021 financial results are set to crush what Cohu delivered in 2020.\n\n\n\nMetric\n2020\n2021 (Estimate)\nGrowth\n\n\n\n\nRevenue\n$636 million\n$902 million\n41%\n\n\nEPS (Loss)\n($0.33)\n$3.05\nN/A\n\n\n\nData source: Cohu, Yahoo! Finance.\nThe company's 41% estimated revenue growth would more than quadruple the 9% it generated in 2020 (when compared to 2019).\nCohu is so comfortable with its financial position right now that it just announced a $70 million share buyback program to return money to shareholders. It's not something investors would typically see from a relatively small $1.5 billion growth company, but it's an added benefit to the 47% rise in share price over the last 12 months.\nWhy you should buy the stock\nWhen it comes to semiconductor stocks, many of them have experienced red-hot share price growth lately as investors price in higher profits from rising demand and low supply. Regardless, Cohu remains incredibly cheap compared to its peers.\nThe iShares Semiconductor ETF trades at a price-to-earnings multiple of 33, compared to a multiple of less than 11 for Cohu based on $3.05 in 2021 EPS. That means the stock would need to triple to align with the broader industry on a valuation basis.\nAnalysts expect Cohu to be just as profitable in 2022, so investors shouldn't be concerned that 2021 was a one-off result following a few years of losses. It aligns with the broader sentiment among car manufacturers, which suggests semiconductor shortages will persist well into the new year. That will only mean one thing: Demand for Cohu's testing and handling equipment is likely to remain elevated.\nCohu's strong third quarter is just another piece in its overwhelmingly positive story. Wall Street is certainly on board, with one firm predicting the stock will more than double from here.","news_type":1},"isVote":1,"tweetType":1,"viewCount":22,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857440863,"gmtCreate":1635557539867,"gmtModify":1635557540806,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Li","listText":"Li","text":"Li","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/857440863","repostId":"2179424781","repostType":4,"repost":{"id":"2179424781","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1635538990,"share":"https://www.laohu8.com/m/news/2179424781?lang=&edition=full","pubTime":"2021-10-30 04:23","market":"hk","language":"en","title":"Wall Street shakes off Amazon, Apple weakness to end modestly higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2179424781","media":"Reuters","summary":"* $Apple$, Amazon fall on dismal holiday-quarter forecast. * $Microsoft$ tops Apple as the most valuable U.S. public company. The S&P 500 had fallen as much as 0.65% earlier in the day. The benchmark index advanced 1.3% for the week, its fourth straight weekly climb, marking its longest weekly streak of gains since April. For the month, the S&P rose 6.9%, its biggest monthly rise since November 2020.The Dow rose 0.4% for the week while the Nasdaq gained 2.7%, also marking four straight weekly ga","content":"<p>* <a href=\"https://laohu8.com/S/AAPL\">Apple</a>, Amazon fall on dismal holiday-quarter forecast</p>\n<p>* <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> tops Apple as the most valuable U.S. public company</p>\n<p>* Dow up 0.25%, S&amp;P 500 up 0.19%, <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> up 0.33%</p>\n<p>(Updates with volume data, market breadth)</p>\n<p>By Chuck Mikolajczak</p>\n<p>NEW YORK, Oct 29 (Reuters) - U.S. stocks shook off early declines and closed out the last trading day of the month with modest gains on Friday as a rise in Microsoft helped offset declines in Amazon and Apple after disappointing quarterly earnings from the online retailer and iPhone maker.</p>\n<p>Microsoft Corp's shares closed at a record high of $331.62 and ended the session with a market capitalization of $2.49 trillion, surpassing Apple Inc's market cap of roughly $2.48 trillion.</p>\n<p>Apple lost 1.81% after it warned the impact of supply-chain disruptions will be even worse during the current holiday sales quarter, while <a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a> Inc declined 2.15% as it forecast downbeat holiday-quarter sales amid labor shortages.</p>\n<p>\"The takeaway from today is the resilience to the overall index despite 10% of market cap in two companies disappointing and yet the market is flat. It’s the resilience of the marketplace, it suggests to me the trend is still intact,\" said David Joy, chief market strategist at <a href=\"https://laohu8.com/S/AMP\">Ameriprise</a> Financial in Boston.</p>\n<p>\"Maybe the numbers were a surprise to the analyst community but not the reasons for the disappointment so there is still a general view that this is not business lost but business postponed and the trend in the economy and in the market continues to be to the upside.\"</p>\n<p>The Dow Jones Industrial Average rose 89.08 points, or 0.25%, to 35,819.56, the S&amp;P 500 gained 8.96 points, or 0.19%, to 4,605.38 and the Nasdaq Composite added 50.27 points, or 0.33%, to 15,498.39.</p>\n<p>The S&amp;P 500 had fallen as much as 0.65% earlier in the day. The benchmark index advanced 1.3% for the week, its fourth straight weekly climb, marking its longest weekly streak of gains since April. For the month, the S&amp;P rose 6.9%, its biggest monthly rise since November 2020.</p>\n<p>The Dow rose 0.4% for the week while the Nasdaq gained 2.7%, also marking four straight weekly gains for each. The Dow climbed 5.8% for October, its best monthly performance since March, while the Nasdaq jumped 7.3% for its biggest monthly percentage gain since November 2020.</p>\n<p>Apple had risen about 2.5% while Amazon gained 1.6% in Thursday's session, helping to send the S&amp;P 500 and Nasdaq to closing record highs.</p>\n<p>With 279 companies in the S&amp;P 500 having reported results through Friday morning, 82.1% have topped earnings expectations, according to Refinitiv data. The current year-over-year earnings growth rate for the third quarter is 39.2%.</p>\n<p>Market participants have been closely attuned to the ability of companies to maneuver through labor shortages, rising price pressures and clogs in the supply chain, and a solid earnings season has helped investors overlook a mixed macroeconomic picture with a Federal Reserve that is poised to begin to trim its massive bond purchases soon.</p>\n<p>The central bank's next policy announcement is on Nov. 3.</p>\n<p>Data showed U.S. consumer spending increased solidly in September, while inflation pressures are broadening.</p>\n<p>The data indicated the jury is still out on whether the Fed's \"transitory\" view on inflation will hold true.</p>\n<p><a href=\"https://laohu8.com/S/ABBV\">AbbVie</a> Inc advanced 4.56% as the U.S. drugmaker raised its 2021 adjusted profit forecast for the third time this year.</p>\n<p><a href=\"https://laohu8.com/S/SBUX\">Starbucks</a> Corp tumbled 6.30% after the coffee chain said it expects fiscal 2022 operating margin to be below its long-term target due to inflation and investments.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.14-to-1 ratio; on Nasdaq, a 1.02-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 50 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 127 new highs and 78 new lows.</p>\n<p>Volume on U.S. exchanges was 11.12 billion shares, compared with the 10.35 billion average for the full session over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street shakes off Amazon, Apple weakness to end modestly higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street shakes off Amazon, Apple weakness to end modestly higher\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-30 04:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* <a href=\"https://laohu8.com/S/AAPL\">Apple</a>, Amazon fall on dismal holiday-quarter forecast</p>\n<p>* <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> tops Apple as the most valuable U.S. public company</p>\n<p>* Dow up 0.25%, S&amp;P 500 up 0.19%, <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> up 0.33%</p>\n<p>(Updates with volume data, market breadth)</p>\n<p>By Chuck Mikolajczak</p>\n<p>NEW YORK, Oct 29 (Reuters) - U.S. stocks shook off early declines and closed out the last trading day of the month with modest gains on Friday as a rise in Microsoft helped offset declines in Amazon and Apple after disappointing quarterly earnings from the online retailer and iPhone maker.</p>\n<p>Microsoft Corp's shares closed at a record high of $331.62 and ended the session with a market capitalization of $2.49 trillion, surpassing Apple Inc's market cap of roughly $2.48 trillion.</p>\n<p>Apple lost 1.81% after it warned the impact of supply-chain disruptions will be even worse during the current holiday sales quarter, while <a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a> Inc declined 2.15% as it forecast downbeat holiday-quarter sales amid labor shortages.</p>\n<p>\"The takeaway from today is the resilience to the overall index despite 10% of market cap in two companies disappointing and yet the market is flat. It’s the resilience of the marketplace, it suggests to me the trend is still intact,\" said David Joy, chief market strategist at <a href=\"https://laohu8.com/S/AMP\">Ameriprise</a> Financial in Boston.</p>\n<p>\"Maybe the numbers were a surprise to the analyst community but not the reasons for the disappointment so there is still a general view that this is not business lost but business postponed and the trend in the economy and in the market continues to be to the upside.\"</p>\n<p>The Dow Jones Industrial Average rose 89.08 points, or 0.25%, to 35,819.56, the S&amp;P 500 gained 8.96 points, or 0.19%, to 4,605.38 and the Nasdaq Composite added 50.27 points, or 0.33%, to 15,498.39.</p>\n<p>The S&amp;P 500 had fallen as much as 0.65% earlier in the day. The benchmark index advanced 1.3% for the week, its fourth straight weekly climb, marking its longest weekly streak of gains since April. For the month, the S&amp;P rose 6.9%, its biggest monthly rise since November 2020.</p>\n<p>The Dow rose 0.4% for the week while the Nasdaq gained 2.7%, also marking four straight weekly gains for each. The Dow climbed 5.8% for October, its best monthly performance since March, while the Nasdaq jumped 7.3% for its biggest monthly percentage gain since November 2020.</p>\n<p>Apple had risen about 2.5% while Amazon gained 1.6% in Thursday's session, helping to send the S&amp;P 500 and Nasdaq to closing record highs.</p>\n<p>With 279 companies in the S&amp;P 500 having reported results through Friday morning, 82.1% have topped earnings expectations, according to Refinitiv data. The current year-over-year earnings growth rate for the third quarter is 39.2%.</p>\n<p>Market participants have been closely attuned to the ability of companies to maneuver through labor shortages, rising price pressures and clogs in the supply chain, and a solid earnings season has helped investors overlook a mixed macroeconomic picture with a Federal Reserve that is poised to begin to trim its massive bond purchases soon.</p>\n<p>The central bank's next policy announcement is on Nov. 3.</p>\n<p>Data showed U.S. consumer spending increased solidly in September, while inflation pressures are broadening.</p>\n<p>The data indicated the jury is still out on whether the Fed's \"transitory\" view on inflation will hold true.</p>\n<p><a href=\"https://laohu8.com/S/ABBV\">AbbVie</a> Inc advanced 4.56% as the U.S. drugmaker raised its 2021 adjusted profit forecast for the third time this year.</p>\n<p><a href=\"https://laohu8.com/S/SBUX\">Starbucks</a> Corp tumbled 6.30% after the coffee chain said it expects fiscal 2022 operating margin to be below its long-term target due to inflation and investments.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.14-to-1 ratio; on Nasdaq, a 1.02-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 50 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 127 new highs and 78 new lows.</p>\n<p>Volume on U.S. exchanges was 11.12 billion shares, compared with the 10.35 billion average for the full session over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软",".DJI":"道琼斯","AAPL":"苹果",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2179424781","content_text":"* Apple, Amazon fall on dismal holiday-quarter forecast\n* Microsoft tops Apple as the most valuable U.S. public company\n* Dow up 0.25%, S&P 500 up 0.19%, Nasdaq up 0.33%\n(Updates with volume data, market breadth)\nBy Chuck Mikolajczak\nNEW YORK, Oct 29 (Reuters) - U.S. stocks shook off early declines and closed out the last trading day of the month with modest gains on Friday as a rise in Microsoft helped offset declines in Amazon and Apple after disappointing quarterly earnings from the online retailer and iPhone maker.\nMicrosoft Corp's shares closed at a record high of $331.62 and ended the session with a market capitalization of $2.49 trillion, surpassing Apple Inc's market cap of roughly $2.48 trillion.\nApple lost 1.81% after it warned the impact of supply-chain disruptions will be even worse during the current holiday sales quarter, while Amazon.com Inc declined 2.15% as it forecast downbeat holiday-quarter sales amid labor shortages.\n\"The takeaway from today is the resilience to the overall index despite 10% of market cap in two companies disappointing and yet the market is flat. It’s the resilience of the marketplace, it suggests to me the trend is still intact,\" said David Joy, chief market strategist at Ameriprise Financial in Boston.\n\"Maybe the numbers were a surprise to the analyst community but not the reasons for the disappointment so there is still a general view that this is not business lost but business postponed and the trend in the economy and in the market continues to be to the upside.\"\nThe Dow Jones Industrial Average rose 89.08 points, or 0.25%, to 35,819.56, the S&P 500 gained 8.96 points, or 0.19%, to 4,605.38 and the Nasdaq Composite added 50.27 points, or 0.33%, to 15,498.39.\nThe S&P 500 had fallen as much as 0.65% earlier in the day. The benchmark index advanced 1.3% for the week, its fourth straight weekly climb, marking its longest weekly streak of gains since April. For the month, the S&P rose 6.9%, its biggest monthly rise since November 2020.\nThe Dow rose 0.4% for the week while the Nasdaq gained 2.7%, also marking four straight weekly gains for each. The Dow climbed 5.8% for October, its best monthly performance since March, while the Nasdaq jumped 7.3% for its biggest monthly percentage gain since November 2020.\nApple had risen about 2.5% while Amazon gained 1.6% in Thursday's session, helping to send the S&P 500 and Nasdaq to closing record highs.\nWith 279 companies in the S&P 500 having reported results through Friday morning, 82.1% have topped earnings expectations, according to Refinitiv data. The current year-over-year earnings growth rate for the third quarter is 39.2%.\nMarket participants have been closely attuned to the ability of companies to maneuver through labor shortages, rising price pressures and clogs in the supply chain, and a solid earnings season has helped investors overlook a mixed macroeconomic picture with a Federal Reserve that is poised to begin to trim its massive bond purchases soon.\nThe central bank's next policy announcement is on Nov. 3.\nData showed U.S. consumer spending increased solidly in September, while inflation pressures are broadening.\nThe data indicated the jury is still out on whether the Fed's \"transitory\" view on inflation will hold true.\nAbbVie Inc advanced 4.56% as the U.S. drugmaker raised its 2021 adjusted profit forecast for the third time this year.\nStarbucks Corp tumbled 6.30% after the coffee chain said it expects fiscal 2022 operating margin to be below its long-term target due to inflation and investments.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.14-to-1 ratio; on Nasdaq, a 1.02-to-1 ratio favored advancers.\nThe S&P 500 posted 50 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 127 new highs and 78 new lows.\nVolume on U.S. exchanges was 11.12 billion shares, compared with the 10.35 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":3,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851524730,"gmtCreate":1634915740066,"gmtModify":1634915743686,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Li","listText":"Li","text":"Li","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/851524730","repostId":"2177415676","repostType":4,"isVote":1,"tweetType":1,"viewCount":40,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829959713,"gmtCreate":1633459313332,"gmtModify":1633459316816,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Li","listText":"Li","text":"Li","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/829959713","repostId":"2173151439","repostType":4,"repost":{"id":"2173151439","pubTimestamp":1633447560,"share":"https://www.laohu8.com/m/news/2173151439?lang=&edition=full","pubTime":"2021-10-05 23:26","market":"us","language":"en","title":"Why Peloton Stock Is Becoming a Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2173151439","media":"Motley Fool","summary":"This exercise equipment maker's stock price is down, but not out.","content":"<p>Share prices of <b>Peloton Interactive</b> (NASDAQ:PTON) are 51% off all-time highs set in mid-January, caught up in an investing trend that instead favors COVID-19 recovery stocks. It hasn't helped that management has made some missteps with its Tread recall, which lost the company a fair amount of goodwill with customers and investors back in April.</p>\n<p>But if we take a step back and look at Peloton as a growth stock, the long-term story is still strong. The company's user base is growing, its product lineup is expanding, and financial performance is getting better. Here's why I think this stock could be a value in today's market.</p>\n<h2>Subscriptions are the key</h2>\n<p>If Peloton is going to be successful as a company, it won't be because it makes or sells bikes. It'll be because it generates growing, high-margin subscription revenue. And on that front, the company is doing very well.</p>\n<p>Subscription revenue was up 132% year over year in the fiscal fourth quarter to $281.6 million, and gross profit from subscriptions was up 159% to $178.1 million.</p>\n<p>The subscription business is also a big reason the company's move into corporate wellness and hotel and resort settings is so important. Peloton has been able to attract millions of active members, but reaching new customers who are allowing others to use their Peloton equipment and subscriptions at rental locations can be another way to leverage the company's equipment and content base.</p>\n<h2>Expanding on a strong core</h2>\n<p>In fiscal 2018, Peloton was almost entirely a stationary cycling company, with cycling accounting for about 85% of the company's workouts. But in the past three years, the company has expanded how people use its products. Strength programs are now about 20% of workouts, and floor content is around 10%. Cycling is now less than 60% of the workouts done in any given year, and shrinking.</p>\n<p>I think this is a sign that Peloton is building a product that's attractive to more users and becoming stickier for subscribers. If Peloton has something for everyone, it's going to provide much more value to subscribers long-term.</p>\n<p>In time, we could even see Peloton slowly raise subscription prices because of the value it's providing.</p>\n<h2>Peloton has growth opportunities ahead</h2>\n<p>After acquiring its own manufacturing facility in the U.S., Peloton now has more control of not only manufacturing and inventory but also new product development. We know a new Tread is on the way, and improved bikes are likely as well.</p>\n<p>I think Peloton could also expand into home strength equipment and even wearables. Peloton is already a critical fitness tool for members, so why not deepen that relationship?</p>\n<p>The company has a lot of opportunities to expand its product footprint and engage even more with customers. As it does, the incremental benefit to users from more digital content makes a Peloton subscription that much more valuable.</p>\n<h2>The growth story isn't over</h2>\n<p>There are a number of potential threats to Peloton's business, from <b>Apple</b>'s growing suite of fitness content to the reopening of gyms around the world. But I think the content library that Peloton has built along with the installed base of bikes and treadmills will make this a formidable fitness company for years. Remember that the value of Peloton is in the number of users subscribing to and using the company's workout content -- and with 459.7 million workouts done by Peloton customers in the last year, this is a workout company that has a huge lead over the competition in at-home workouts.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Peloton Stock Is Becoming a Value</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Peloton Stock Is Becoming a Value\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-05 23:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/05/why-peloton-stock-is-now-a-value/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Share prices of Peloton Interactive (NASDAQ:PTON) are 51% off all-time highs set in mid-January, caught up in an investing trend that instead favors COVID-19 recovery stocks. It hasn't helped that ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/05/why-peloton-stock-is-now-a-value/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTON":"Peloton Interactive, Inc."},"source_url":"https://www.fool.com/investing/2021/10/05/why-peloton-stock-is-now-a-value/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173151439","content_text":"Share prices of Peloton Interactive (NASDAQ:PTON) are 51% off all-time highs set in mid-January, caught up in an investing trend that instead favors COVID-19 recovery stocks. It hasn't helped that management has made some missteps with its Tread recall, which lost the company a fair amount of goodwill with customers and investors back in April.\nBut if we take a step back and look at Peloton as a growth stock, the long-term story is still strong. The company's user base is growing, its product lineup is expanding, and financial performance is getting better. Here's why I think this stock could be a value in today's market.\nSubscriptions are the key\nIf Peloton is going to be successful as a company, it won't be because it makes or sells bikes. It'll be because it generates growing, high-margin subscription revenue. And on that front, the company is doing very well.\nSubscription revenue was up 132% year over year in the fiscal fourth quarter to $281.6 million, and gross profit from subscriptions was up 159% to $178.1 million.\nThe subscription business is also a big reason the company's move into corporate wellness and hotel and resort settings is so important. Peloton has been able to attract millions of active members, but reaching new customers who are allowing others to use their Peloton equipment and subscriptions at rental locations can be another way to leverage the company's equipment and content base.\nExpanding on a strong core\nIn fiscal 2018, Peloton was almost entirely a stationary cycling company, with cycling accounting for about 85% of the company's workouts. But in the past three years, the company has expanded how people use its products. Strength programs are now about 20% of workouts, and floor content is around 10%. Cycling is now less than 60% of the workouts done in any given year, and shrinking.\nI think this is a sign that Peloton is building a product that's attractive to more users and becoming stickier for subscribers. If Peloton has something for everyone, it's going to provide much more value to subscribers long-term.\nIn time, we could even see Peloton slowly raise subscription prices because of the value it's providing.\nPeloton has growth opportunities ahead\nAfter acquiring its own manufacturing facility in the U.S., Peloton now has more control of not only manufacturing and inventory but also new product development. We know a new Tread is on the way, and improved bikes are likely as well.\nI think Peloton could also expand into home strength equipment and even wearables. Peloton is already a critical fitness tool for members, so why not deepen that relationship?\nThe company has a lot of opportunities to expand its product footprint and engage even more with customers. As it does, the incremental benefit to users from more digital content makes a Peloton subscription that much more valuable.\nThe growth story isn't over\nThere are a number of potential threats to Peloton's business, from Apple's growing suite of fitness content to the reopening of gyms around the world. But I think the content library that Peloton has built along with the installed base of bikes and treadmills will make this a formidable fitness company for years. Remember that the value of Peloton is in the number of users subscribing to and using the company's workout content -- and with 459.7 million workouts done by Peloton customers in the last year, this is a workout company that has a huge lead over the competition in at-home workouts.","news_type":1},"isVote":1,"tweetType":1,"viewCount":3,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696351122,"gmtCreate":1640624037578,"gmtModify":1640624040127,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/696351122","repostId":"1102433799","repostType":4,"repost":{"id":"1102433799","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640617949,"share":"https://www.laohu8.com/m/news/1102433799?lang=&edition=full","pubTime":"2021-12-27 23:12","market":"us","language":"en","title":"Gaming stocks rose in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1102433799","media":"Tiger Newspress","summary":"Gaming stocks rose in morning trading.Roblox,Unity Software&nbsp;and&nbsp;AppLovin&nbsp;climbed between 1% and 3%.","content":"<p>Gaming stocks rose in morning trading.Roblox,Unity Software&nbsp;and&nbsp;AppLovin&nbsp;climbed between 1% and 3%.</p>\n<p><img src=\"https://static.tigerbbs.com/580cc77260d26ccb370ef7f324be78b5\" tg-width=\"419\" tg-height=\"419\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gaming stocks rose in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGaming stocks rose in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-27 23:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Gaming stocks rose in morning trading.Roblox,Unity Software&nbsp;and&nbsp;AppLovin&nbsp;climbed between 1% and 3%.</p>\n<p><img src=\"https://static.tigerbbs.com/580cc77260d26ccb370ef7f324be78b5\" tg-width=\"419\" tg-height=\"419\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RBLX":"Roblox Corporation"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102433799","content_text":"Gaming stocks rose in morning trading.Roblox,Unity Software and AppLovin climbed between 1% and 3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":749,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698569131,"gmtCreate":1640457159831,"gmtModify":1640457162542,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698569131","repostId":"2193720178","repostType":4,"repost":{"id":"2193720178","pubTimestamp":1640398065,"share":"https://www.laohu8.com/m/news/2193720178?lang=&edition=full","pubTime":"2021-12-25 10:07","market":"us","language":"en","title":"2 Top Stocks to Buy for the New Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2193720178","media":"Motley Fool","summary":"Two very different companies -- one in tech and one in retail -- offer investors long-term growth potential and durable business models.","content":"<p>With talks of likely interest rate hikes from the Federal Reserve in 2022 and the coronavirus pandemic still making the rounds, one key characteristic investors should look for in investments going into the new year is resilience. In other words, some good traits to look for are valuations that make sense relative to a company's growth trajectory and market opportunity, and durable business models with proven track records. While there's no way to avoid volatility, owning resilient companies can at least help investors better weather near-term challenges (mentally and emotionally) since they know their investments have what it takes to endure.</p>\n<p>Two companies that fit this description are <b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b> (NASDAQ:FB) and <b><a href=\"https://laohu8.com/S/TSCO\">Tractor Supply Company</a></b> (NASDAQ:TSCO). Here's a look at why both of these stocks are good bets for 2022 and beyond.</p>\n<h2>Meta Platforms</h2>\n<p>The case for Meta Platforms is straightforward. The tech stock's valuation is very cheap relative to the company's recent growth. Consider that the Facebook parent's trailing-12-month revenue and net income of $112 billion and $40 billion, respectively, are up from $71 billion and $18 billion in 2019. Even with such staggering recent growth, Meta Platforms trades at only 24 times its current level of earnings.</p>\n<p>While the company is running into some near-term growth headwinds related to <b>Apple</b>'s recent changes to advertising tracking and measurement, it's not like the suppressed growth Meta Platforms is expecting is poor. Management guided for fourth-quarter revenue to be between $31.5 billion and $34 billion. The midpoint of this guidance range represents 17% revenue growth. Further, analysts are still modeling for exceptional earnings-per-share growth over the next five years. On average, analysts currently expect Meta Platforms' earnings per share to compound at a growth rate of 21% annually over this period.</p>\n<p>Meta Platforms' network effect of billions of monthly active users makes its business very durable. Not only has the company's core Facebook platform consistently grown larger with no close challenger, but the company's other social networks with more intense competition (namely Instagram) have shown they can easily deploy features that imitate successful competitors, helping them stay relevant.</p>\n<h2>Tractor Supply Company</h2>\n<p>Some city folk may have never even stepped foot in a Tractor Supply store. But investors shouldn't overlook this investment just because they're not familiar with the retailer. Tractor Supply, which specializes in rural lifestyle, has a strong retail niche and is capitalizing well on several different important growth catalysts, including private label and exclusive brands, pet food, and e-commerce. Its balanced business has helped revenue grow 24% year over year in the trailing 12 months, and helped earnings per share grow 22%.</p>\n<p>Tractor Supply is notably mastering e-commerce in a market where many of its customers live farther apart than people do in the city. These communities come with unique challenges that Tractor Supply is able to develop expertise in, and the company's strategy is working. Tractor Supply said on its most recent earnings call that its e-commerce sales increased at a rate faster than 40% year over year.</p>\n<p>While the stock's price-to-earnings ratio of 29 isn't exactly cheap, the company's positioning as the lead retailer for the rural lifestyle makes this business worth paying up for. Given how specialized Tractor Supply is, it would be very difficult for a competitor to topple it. The company also pays a dividend and is regularly repurchasing shares, supplementing shareholder value creation.</p>\n<p>Facebook and Tractor Supply together represent two solid ideas from very different industries that provide meaningful long-term growth potential for investors.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Top Stocks to Buy for the New Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Top Stocks to Buy for the New Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/2-top-stocks-to-buy-for-the-new-year/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With talks of likely interest rate hikes from the Federal Reserve in 2022 and the coronavirus pandemic still making the rounds, one key characteristic investors should look for in investments going ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/2-top-stocks-to-buy-for-the-new-year/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSCO":"拖拉机供应公司"},"source_url":"https://www.fool.com/investing/2021/12/24/2-top-stocks-to-buy-for-the-new-year/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193720178","content_text":"With talks of likely interest rate hikes from the Federal Reserve in 2022 and the coronavirus pandemic still making the rounds, one key characteristic investors should look for in investments going into the new year is resilience. In other words, some good traits to look for are valuations that make sense relative to a company's growth trajectory and market opportunity, and durable business models with proven track records. While there's no way to avoid volatility, owning resilient companies can at least help investors better weather near-term challenges (mentally and emotionally) since they know their investments have what it takes to endure.\nTwo companies that fit this description are Meta Platforms (NASDAQ:FB) and Tractor Supply Company (NASDAQ:TSCO). Here's a look at why both of these stocks are good bets for 2022 and beyond.\nMeta Platforms\nThe case for Meta Platforms is straightforward. The tech stock's valuation is very cheap relative to the company's recent growth. Consider that the Facebook parent's trailing-12-month revenue and net income of $112 billion and $40 billion, respectively, are up from $71 billion and $18 billion in 2019. Even with such staggering recent growth, Meta Platforms trades at only 24 times its current level of earnings.\nWhile the company is running into some near-term growth headwinds related to Apple's recent changes to advertising tracking and measurement, it's not like the suppressed growth Meta Platforms is expecting is poor. Management guided for fourth-quarter revenue to be between $31.5 billion and $34 billion. The midpoint of this guidance range represents 17% revenue growth. Further, analysts are still modeling for exceptional earnings-per-share growth over the next five years. On average, analysts currently expect Meta Platforms' earnings per share to compound at a growth rate of 21% annually over this period.\nMeta Platforms' network effect of billions of monthly active users makes its business very durable. Not only has the company's core Facebook platform consistently grown larger with no close challenger, but the company's other social networks with more intense competition (namely Instagram) have shown they can easily deploy features that imitate successful competitors, helping them stay relevant.\nTractor Supply Company\nSome city folk may have never even stepped foot in a Tractor Supply store. But investors shouldn't overlook this investment just because they're not familiar with the retailer. Tractor Supply, which specializes in rural lifestyle, has a strong retail niche and is capitalizing well on several different important growth catalysts, including private label and exclusive brands, pet food, and e-commerce. Its balanced business has helped revenue grow 24% year over year in the trailing 12 months, and helped earnings per share grow 22%.\nTractor Supply is notably mastering e-commerce in a market where many of its customers live farther apart than people do in the city. These communities come with unique challenges that Tractor Supply is able to develop expertise in, and the company's strategy is working. Tractor Supply said on its most recent earnings call that its e-commerce sales increased at a rate faster than 40% year over year.\nWhile the stock's price-to-earnings ratio of 29 isn't exactly cheap, the company's positioning as the lead retailer for the rural lifestyle makes this business worth paying up for. Given how specialized Tractor Supply is, it would be very difficult for a competitor to topple it. The company also pays a dividend and is regularly repurchasing shares, supplementing shareholder value creation.\nFacebook and Tractor Supply together represent two solid ideas from very different industries that provide meaningful long-term growth potential for investors.","news_type":1},"isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874690378,"gmtCreate":1637764609662,"gmtModify":1637764610631,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/874690378","repostId":"1149443792","repostType":4,"repost":{"id":"1149443792","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637764212,"share":"https://www.laohu8.com/m/news/1149443792?lang=&edition=full","pubTime":"2021-11-24 22:30","market":"us","language":"en","title":"Stocks fall as higher yields hit tech names again, retail earnings disappoint","url":"https://stock-news.laohu8.com/highlight/detail?id=1149443792","media":"Tiger Newspress","summary":"U.S. stocks fell at the open on Wednesday morning as higher yields continued to put pressure on high","content":"<p>U.S. stocks fell at the open on Wednesday morning as higher yields continued to put pressure on high-flying tech stocks.</p>\n<p>The Dow Jones Industrial Averaged shed 200 points, or about 0.6%. The S&amp;P 500 lose 0.6%, while the tech-heavy Nasdaq Composit slid 0.9%.</p>\n<p>The three major indexes held lower even after new Labor Department data showed new&nbsp;weekly jobless claims&nbsp;fell far more than expected to their lowest level since November 1969, underscoring the current tight labor market conditions. The 10-year Treasury yield rose to near 1.7% amid these further signs of a firming economic recovery.</p>\n<p>Rising interest rates have coincided with a selloff in tech and growth stocks this week, with the Nasdaq dropping another 0.5% on Tuesday after Monday's more than 1% decline.</p>\n<p>\"Initially, the markets were happy with the FOMC decision [for Fed Chair Jerome Powell'srenomination] in the sense that it was sort of a continuity play to some degree. But then rates started to rise, and a lot of folks read rising rates as negative for big-cap tech,\" Stuart Kaiser, UBS head of equity derivatives research,told Yahoo Finance Live.\"So I think the tradeoff we're going to have here is that, tech has been market leadership — it's obviously a strong earnings growth and free cash flow engine for U.S. equities — but if you believe it's going to come under pressure from higher yields, then you end up with kind of a difficult Catch-22.\"</p>\n<p>Investors are set to receive more economic data later Wednesday morning ahead of the Thanksgiving Day market holiday, with both the U.S. stock and bond markets set to close all day Thursday. Importantly, the Bureau of Economic Analysis will release the October personal consumption expenditures (PCE) deflator, offering an updated look at the extent of the price increases still reverberating through the U.S. economy.</p>\n<p>The headline PCE deflator is expected to rise by 5.1% in October over last year for its fastest annual growth rate in more than three decades. Taken in tandem with a bevy of other data pointing to persistently high inflation, investors are speculating that the Federal Reserve will step in and raise benchmark interest rates from their near-zero levels next year to try and stem rising prices.</p>\n<p>According to other analysts, the market action this week — with a renewed rotation away from technology and growth stocks in the face of rising rates — could presage the investing environment for next year.</p>\n<p>\"[Tuesday] might be an example of what we see more of next year as the Fed moves into a mode of withdrawing liquidity from the markets and ending these pandemic-era policies, perhaps with rate hikes at the end of the year,\" Jeffrey Kleintop, Charles Schwab chief global investment strategist,told Yahoo Finance Live.\"And that means higher-valuation stocks, well, they tend to not do as well in environments of rising interest rates and tighter financial conditions.\"</p>\n<p>\"So you may want to look to be in those sectors that are maybe trading closer to their average valuations, looking to leadership like financials, energy,\" he added. \"The only caveat to that is when we see these upticks in COVID cases globally, it tends to favor those lockdown defensives like technology.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks fall as higher yields hit tech names again, retail earnings disappoint</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks fall as higher yields hit tech names again, retail earnings disappoint\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-24 22:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stocks fell at the open on Wednesday morning as higher yields continued to put pressure on high-flying tech stocks.</p>\n<p>The Dow Jones Industrial Averaged shed 200 points, or about 0.6%. The S&amp;P 500 lose 0.6%, while the tech-heavy Nasdaq Composit slid 0.9%.</p>\n<p>The three major indexes held lower even after new Labor Department data showed new&nbsp;weekly jobless claims&nbsp;fell far more than expected to their lowest level since November 1969, underscoring the current tight labor market conditions. The 10-year Treasury yield rose to near 1.7% amid these further signs of a firming economic recovery.</p>\n<p>Rising interest rates have coincided with a selloff in tech and growth stocks this week, with the Nasdaq dropping another 0.5% on Tuesday after Monday's more than 1% decline.</p>\n<p>\"Initially, the markets were happy with the FOMC decision [for Fed Chair Jerome Powell'srenomination] in the sense that it was sort of a continuity play to some degree. But then rates started to rise, and a lot of folks read rising rates as negative for big-cap tech,\" Stuart Kaiser, UBS head of equity derivatives research,told Yahoo Finance Live.\"So I think the tradeoff we're going to have here is that, tech has been market leadership — it's obviously a strong earnings growth and free cash flow engine for U.S. equities — but if you believe it's going to come under pressure from higher yields, then you end up with kind of a difficult Catch-22.\"</p>\n<p>Investors are set to receive more economic data later Wednesday morning ahead of the Thanksgiving Day market holiday, with both the U.S. stock and bond markets set to close all day Thursday. Importantly, the Bureau of Economic Analysis will release the October personal consumption expenditures (PCE) deflator, offering an updated look at the extent of the price increases still reverberating through the U.S. economy.</p>\n<p>The headline PCE deflator is expected to rise by 5.1% in October over last year for its fastest annual growth rate in more than three decades. Taken in tandem with a bevy of other data pointing to persistently high inflation, investors are speculating that the Federal Reserve will step in and raise benchmark interest rates from their near-zero levels next year to try and stem rising prices.</p>\n<p>According to other analysts, the market action this week — with a renewed rotation away from technology and growth stocks in the face of rising rates — could presage the investing environment for next year.</p>\n<p>\"[Tuesday] might be an example of what we see more of next year as the Fed moves into a mode of withdrawing liquidity from the markets and ending these pandemic-era policies, perhaps with rate hikes at the end of the year,\" Jeffrey Kleintop, Charles Schwab chief global investment strategist,told Yahoo Finance Live.\"And that means higher-valuation stocks, well, they tend to not do as well in environments of rising interest rates and tighter financial conditions.\"</p>\n<p>\"So you may want to look to be in those sectors that are maybe trading closer to their average valuations, looking to leadership like financials, energy,\" he added. \"The only caveat to that is when we see these upticks in COVID cases globally, it tends to favor those lockdown defensives like technology.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149443792","content_text":"U.S. stocks fell at the open on Wednesday morning as higher yields continued to put pressure on high-flying tech stocks.\nThe Dow Jones Industrial Averaged shed 200 points, or about 0.6%. The S&P 500 lose 0.6%, while the tech-heavy Nasdaq Composit slid 0.9%.\nThe three major indexes held lower even after new Labor Department data showed new weekly jobless claims fell far more than expected to their lowest level since November 1969, underscoring the current tight labor market conditions. The 10-year Treasury yield rose to near 1.7% amid these further signs of a firming economic recovery.\nRising interest rates have coincided with a selloff in tech and growth stocks this week, with the Nasdaq dropping another 0.5% on Tuesday after Monday's more than 1% decline.\n\"Initially, the markets were happy with the FOMC decision [for Fed Chair Jerome Powell'srenomination] in the sense that it was sort of a continuity play to some degree. But then rates started to rise, and a lot of folks read rising rates as negative for big-cap tech,\" Stuart Kaiser, UBS head of equity derivatives research,told Yahoo Finance Live.\"So I think the tradeoff we're going to have here is that, tech has been market leadership — it's obviously a strong earnings growth and free cash flow engine for U.S. equities — but if you believe it's going to come under pressure from higher yields, then you end up with kind of a difficult Catch-22.\"\nInvestors are set to receive more economic data later Wednesday morning ahead of the Thanksgiving Day market holiday, with both the U.S. stock and bond markets set to close all day Thursday. Importantly, the Bureau of Economic Analysis will release the October personal consumption expenditures (PCE) deflator, offering an updated look at the extent of the price increases still reverberating through the U.S. economy.\nThe headline PCE deflator is expected to rise by 5.1% in October over last year for its fastest annual growth rate in more than three decades. Taken in tandem with a bevy of other data pointing to persistently high inflation, investors are speculating that the Federal Reserve will step in and raise benchmark interest rates from their near-zero levels next year to try and stem rising prices.\nAccording to other analysts, the market action this week — with a renewed rotation away from technology and growth stocks in the face of rising rates — could presage the investing environment for next year.\n\"[Tuesday] might be an example of what we see more of next year as the Fed moves into a mode of withdrawing liquidity from the markets and ending these pandemic-era policies, perhaps with rate hikes at the end of the year,\" Jeffrey Kleintop, Charles Schwab chief global investment strategist,told Yahoo Finance Live.\"And that means higher-valuation stocks, well, they tend to not do as well in environments of rising interest rates and tighter financial conditions.\"\n\"So you may want to look to be in those sectors that are maybe trading closer to their average valuations, looking to leadership like financials, energy,\" he added. \"The only caveat to that is when we see these upticks in COVID cases globally, it tends to favor those lockdown defensives like technology.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821778055,"gmtCreate":1633805361449,"gmtModify":1633805362228,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Li","listText":"Li","text":"Li","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/821778055","repostId":"2174920514","repostType":4,"repost":{"id":"2174920514","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1633764600,"share":"https://www.laohu8.com/m/news/2174920514?lang=&edition=full","pubTime":"2021-10-09 15:30","market":"us","language":"en","title":"Is the stock market open on Columbus Day? Yes! But the bond market isn't--Here's why","url":"https://stock-news.laohu8.com/highlight/detail?id=2174920514","media":"Dow Jones","summary":"It's also Indigenous Peoples Day.\nIt's almost a perennial question on Wall Street. With Columbus Day","content":"<p>It's also Indigenous Peoples Day.</p>\n<p>It's almost a perennial question on Wall Street. With Columbus Day a federal holiday on Monday, investors are curious if the stock market will be opened.</p>\n<p>Here is the short answer: yes. But it isn't that simple.</p>\n<p>The bond market isn't. Bond traders are off as recommended by the Securities Industry and Financial Markets Association, known as Sifma.</p>\n<p>Columbus Day and Veterans Day are the two federal holidays when fixed-income markets are closed due to the federal holiday.</p>\n<p>As per usual, the Intercontinental Exchange<a href=\"https://laohu8.com/S/ICE\">$(ICE)$</a>-owned New York Stock Exchange and the Nasdaq Inc. <a href=\"https://laohu8.com/S/NDAQ\">$(NDAQ)$</a> will both be open regular hours. So, the Dow Jones Industrial Average , the S&amp;P 500 index and the Nasdaq Composite Index , to note the three main U.S. bourses, can figure out whether the weaker-than-expected jobs report released on Friday was bullish or bearish in the near term.</p>\n<p>Meanwhile, benchmark bonds can take a breather after the 10-year Treasury note yield, 30-year Treasury bond and 2-year Treasury note touched their highest yields in months (since March of 2020 in the case of the shorter-date debt).</p>\n<p>Now back to Columbus Day and the curious case of mixed up market closures.</p>\n<p>Here's perhaps why it is closed and equities trade on.</p>\n<p>Begun back in 1792 and declared a federal day off in 1937 by President Franklin D. Roosevelt, Columbus Day marks a state and federal holiday. Federal offices, including the U.S. Treasury Department, are closed. That means, Treasurys--a chunk of typical trading activity on regular days and a key benchmark--are also forced to take a holiday.</p>\n<p>Columbus Day isn't without its controversy as a holiday intended to celebrate Christopher Columbus for sailing the ocean blue in 1492. Firstly, not all states celebrate the Italian explorer's occasion on the same day. Tennessee tends to celebrate the holiday on Friday. Some states don't acknowledge the day at all, with Alaska, Vermont, Hawaii and South Dakota choosing not to observe it.</p>\n<p>Some regions choose to celebrate Indigenous Peoples Day, which honors Native Americans and challenges the concept that Columbus was the first to discover America. The holiday has been gaining support, as an alternative to Columbus Day.</p>\n<p>So, the next time that someone asks if the market is open on Columbus Day, you can tell them that it is complicated.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is the stock market open on Columbus Day? Yes! But the bond market isn't--Here's why</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs the stock market open on Columbus Day? Yes! But the bond market isn't--Here's why\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-10-09 15:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>It's also Indigenous Peoples Day.</p>\n<p>It's almost a perennial question on Wall Street. With Columbus Day a federal holiday on Monday, investors are curious if the stock market will be opened.</p>\n<p>Here is the short answer: yes. But it isn't that simple.</p>\n<p>The bond market isn't. Bond traders are off as recommended by the Securities Industry and Financial Markets Association, known as Sifma.</p>\n<p>Columbus Day and Veterans Day are the two federal holidays when fixed-income markets are closed due to the federal holiday.</p>\n<p>As per usual, the Intercontinental Exchange<a href=\"https://laohu8.com/S/ICE\">$(ICE)$</a>-owned New York Stock Exchange and the Nasdaq Inc. <a href=\"https://laohu8.com/S/NDAQ\">$(NDAQ)$</a> will both be open regular hours. So, the Dow Jones Industrial Average , the S&amp;P 500 index and the Nasdaq Composite Index , to note the three main U.S. bourses, can figure out whether the weaker-than-expected jobs report released on Friday was bullish or bearish in the near term.</p>\n<p>Meanwhile, benchmark bonds can take a breather after the 10-year Treasury note yield, 30-year Treasury bond and 2-year Treasury note touched their highest yields in months (since March of 2020 in the case of the shorter-date debt).</p>\n<p>Now back to Columbus Day and the curious case of mixed up market closures.</p>\n<p>Here's perhaps why it is closed and equities trade on.</p>\n<p>Begun back in 1792 and declared a federal day off in 1937 by President Franklin D. Roosevelt, Columbus Day marks a state and federal holiday. Federal offices, including the U.S. Treasury Department, are closed. That means, Treasurys--a chunk of typical trading activity on regular days and a key benchmark--are also forced to take a holiday.</p>\n<p>Columbus Day isn't without its controversy as a holiday intended to celebrate Christopher Columbus for sailing the ocean blue in 1492. Firstly, not all states celebrate the Italian explorer's occasion on the same day. Tennessee tends to celebrate the holiday on Friday. Some states don't acknowledge the day at all, with Alaska, Vermont, Hawaii and South Dakota choosing not to observe it.</p>\n<p>Some regions choose to celebrate Indigenous Peoples Day, which honors Native Americans and challenges the concept that Columbus was the first to discover America. The holiday has been gaining support, as an alternative to Columbus Day.</p>\n<p>So, the next time that someone asks if the market is open on Columbus Day, you can tell them that it is complicated.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","NDAQ":"纳斯达克OMX交易所","ICE":"洲际交易所",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2174920514","content_text":"It's also Indigenous Peoples Day.\nIt's almost a perennial question on Wall Street. With Columbus Day a federal holiday on Monday, investors are curious if the stock market will be opened.\nHere is the short answer: yes. But it isn't that simple.\nThe bond market isn't. Bond traders are off as recommended by the Securities Industry and Financial Markets Association, known as Sifma.\nColumbus Day and Veterans Day are the two federal holidays when fixed-income markets are closed due to the federal holiday.\nAs per usual, the Intercontinental Exchange$(ICE)$-owned New York Stock Exchange and the Nasdaq Inc. $(NDAQ)$ will both be open regular hours. So, the Dow Jones Industrial Average , the S&P 500 index and the Nasdaq Composite Index , to note the three main U.S. bourses, can figure out whether the weaker-than-expected jobs report released on Friday was bullish or bearish in the near term.\nMeanwhile, benchmark bonds can take a breather after the 10-year Treasury note yield, 30-year Treasury bond and 2-year Treasury note touched their highest yields in months (since March of 2020 in the case of the shorter-date debt).\nNow back to Columbus Day and the curious case of mixed up market closures.\nHere's perhaps why it is closed and equities trade on.\nBegun back in 1792 and declared a federal day off in 1937 by President Franklin D. Roosevelt, Columbus Day marks a state and federal holiday. Federal offices, including the U.S. Treasury Department, are closed. That means, Treasurys--a chunk of typical trading activity on regular days and a key benchmark--are also forced to take a holiday.\nColumbus Day isn't without its controversy as a holiday intended to celebrate Christopher Columbus for sailing the ocean blue in 1492. Firstly, not all states celebrate the Italian explorer's occasion on the same day. Tennessee tends to celebrate the holiday on Friday. Some states don't acknowledge the day at all, with Alaska, Vermont, Hawaii and South Dakota choosing not to observe it.\nSome regions choose to celebrate Indigenous Peoples Day, which honors Native Americans and challenges the concept that Columbus was the first to discover America. The holiday has been gaining support, as an alternative to Columbus Day.\nSo, the next time that someone asks if the market is open on Columbus Day, you can tell them that it is complicated.","news_type":1},"isVote":1,"tweetType":1,"viewCount":42,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699612608,"gmtCreate":1639791240785,"gmtModify":1639791308119,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/699612608","repostId":"1155244596","repostType":4,"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841010013,"gmtCreate":1635862537867,"gmtModify":1635862538793,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Li","listText":"Li","text":"Li","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/841010013","repostId":"1163085565","repostType":4,"repost":{"id":"1163085565","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635862319,"share":"https://www.laohu8.com/m/news/1163085565?lang=&edition=full","pubTime":"2021-11-02 22:11","market":"us","language":"en","title":"Bionano Genomics shares surged more than 10% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1163085565","media":"Tiger Newspress","summary":"Bionano Genomics shares surged more than 10% in morning trading.\n\nPersonalized medicine is the holy ","content":"<p>Bionano Genomics shares surged more than 10% in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/341f797630babaf15e0ae9aa0dbd5c7d\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Personalized medicine is the holy grail of biotech research. Despite numerous breakthroughs in the treatment of cancer with the advent of immunotherapy, a clinical success in this field is generally characterized by response rates as low as 30%. Researchers believe that these exceedingly low response rates stem from differences in the mutation type at both the nucleic acid and whole chromosomal level within a particular patient population. Cancer, in effect, is not a monolithic disease, making it impossible to develop a one-size-fits-all type of therapy.</p>\n<p>To boost the efficacy of these novel anti-cancer treatments, researchers thus require an accurate picture of the malignancy's genetic architecture at the individual level. That's where a company like Bionano Genomics comes into play. Bionano Genomicssportsa non-sequencing-based optical mapping technology known as the Saphyr System. The Saphyr System is designed to rapidly characterize extremely long strands of genomic DNA.</p>\n<p>What's more, the biotech recently acquired the leading genomics data analysis software company BioDiscovery. This landmark acquisition could turn out to be a game-changing business development move for the company and its shareholders. In brief, BioDiscovery's NXClinical software solution for variant analysis, combined with the Saphyr System, has the potential to accelerate the adoption of optical genome mapping at large. Moreover, this potentially best-in-class platform might ultimately grab an outsize portion of this multi-billion dollar market within the next few years.</p>\n<p>Bionano is slated to report third-quarter earnings on Nov. 4. While the biotech's Q3 revenue figure is unlikely to turn heads, investors should learn more about the long-term implications of this key acquisition. As a result, Bionano's beaten-down stock might finally start to show some signs of life after an eight-month downturn. Underscoring this point, the biotech's shares are currently down by a whopping 67% relative to their 52-week highs. Aggressive investors, in turn, may want to pick up some shares ahead of this upcoming earnings report.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bionano Genomics shares surged more than 10% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBionano Genomics shares surged more than 10% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-02 22:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bionano Genomics shares surged more than 10% in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/341f797630babaf15e0ae9aa0dbd5c7d\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Personalized medicine is the holy grail of biotech research. Despite numerous breakthroughs in the treatment of cancer with the advent of immunotherapy, a clinical success in this field is generally characterized by response rates as low as 30%. Researchers believe that these exceedingly low response rates stem from differences in the mutation type at both the nucleic acid and whole chromosomal level within a particular patient population. Cancer, in effect, is not a monolithic disease, making it impossible to develop a one-size-fits-all type of therapy.</p>\n<p>To boost the efficacy of these novel anti-cancer treatments, researchers thus require an accurate picture of the malignancy's genetic architecture at the individual level. That's where a company like Bionano Genomics comes into play. Bionano Genomicssportsa non-sequencing-based optical mapping technology known as the Saphyr System. The Saphyr System is designed to rapidly characterize extremely long strands of genomic DNA.</p>\n<p>What's more, the biotech recently acquired the leading genomics data analysis software company BioDiscovery. This landmark acquisition could turn out to be a game-changing business development move for the company and its shareholders. In brief, BioDiscovery's NXClinical software solution for variant analysis, combined with the Saphyr System, has the potential to accelerate the adoption of optical genome mapping at large. Moreover, this potentially best-in-class platform might ultimately grab an outsize portion of this multi-billion dollar market within the next few years.</p>\n<p>Bionano is slated to report third-quarter earnings on Nov. 4. While the biotech's Q3 revenue figure is unlikely to turn heads, investors should learn more about the long-term implications of this key acquisition. As a result, Bionano's beaten-down stock might finally start to show some signs of life after an eight-month downturn. Underscoring this point, the biotech's shares are currently down by a whopping 67% relative to their 52-week highs. Aggressive investors, in turn, may want to pick up some shares ahead of this upcoming earnings report.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163085565","content_text":"Bionano Genomics shares surged more than 10% in morning trading.\n\nPersonalized medicine is the holy grail of biotech research. Despite numerous breakthroughs in the treatment of cancer with the advent of immunotherapy, a clinical success in this field is generally characterized by response rates as low as 30%. Researchers believe that these exceedingly low response rates stem from differences in the mutation type at both the nucleic acid and whole chromosomal level within a particular patient population. Cancer, in effect, is not a monolithic disease, making it impossible to develop a one-size-fits-all type of therapy.\nTo boost the efficacy of these novel anti-cancer treatments, researchers thus require an accurate picture of the malignancy's genetic architecture at the individual level. That's where a company like Bionano Genomics comes into play. Bionano Genomicssportsa non-sequencing-based optical mapping technology known as the Saphyr System. The Saphyr System is designed to rapidly characterize extremely long strands of genomic DNA.\nWhat's more, the biotech recently acquired the leading genomics data analysis software company BioDiscovery. This landmark acquisition could turn out to be a game-changing business development move for the company and its shareholders. In brief, BioDiscovery's NXClinical software solution for variant analysis, combined with the Saphyr System, has the potential to accelerate the adoption of optical genome mapping at large. Moreover, this potentially best-in-class platform might ultimately grab an outsize portion of this multi-billion dollar market within the next few years.\nBionano is slated to report third-quarter earnings on Nov. 4. While the biotech's Q3 revenue figure is unlikely to turn heads, investors should learn more about the long-term implications of this key acquisition. As a result, Bionano's beaten-down stock might finally start to show some signs of life after an eight-month downturn. Underscoring this point, the biotech's shares are currently down by a whopping 67% relative to their 52-week highs. Aggressive investors, in turn, may want to pick up some shares ahead of this upcoming earnings report.","news_type":1},"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":827873620,"gmtCreate":1634450476188,"gmtModify":1634450479666,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Li","listText":"Li","text":"Li","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/827873620","repostId":"2175146556","repostType":4,"isVote":1,"tweetType":1,"viewCount":47,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865497151,"gmtCreate":1633009498328,"gmtModify":1633009580330,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Li","listText":"Li","text":"Li","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/865497151","repostId":"1190243332","repostType":4,"repost":{"id":"1190243332","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633008705,"share":"https://www.laohu8.com/m/news/1190243332?lang=&edition=full","pubTime":"2021-09-30 21:31","market":"us","language":"en","title":"Stocks rise slightly as Wall Street tries to end losing month on a high note","url":"https://stock-news.laohu8.com/highlight/detail?id=1190243332","media":"Tiger Newspress","summary":"U.S. stocks rose slightly on Thursday as investors get to close out a volatile and losing month for ","content":"<p>U.S. stocks rose slightly on Thursday as investors get to close out a volatile and losing month for stocks.</p>\n<p>The Dow Jones Industrial Average gained 107 points, or 0.3%. The S&amp;P 500 added 0.4% and Nasdaq Composite gained 0.6%.</p>\n<p>Tech stocks bounced a bit in morning trading after struggling this week because of a rapid rise in rates. The&nbsp;10-year Treasury yield&nbsp;was little changed in early trading.</p>\n<p>Chip stocks, including Nvidia and Micron, were higher after weighing on the broader market on Wednesday. Facebook and Apple saw modest gains in early trading, while Netflix jumped more than 2%.</p>\n<p>Stocks also got a boost as Senate Majority Leader Chuck Schumer said late Wednesday that the chamber had reached a deal to avoid a government shutdown this week. Schumer said&nbsp;he would schedule a vote on Thursday&nbsp;for the stopgap measure that would keep the government running into early December. The deal would still need to pass the House.</p>\n<p>For the month, the Dow is down 2.7%, the S&amp;P 500 is off by 3.6% and the Nasdaq Composite has shed 4.9%. September has lived up to its losing reputation with the market beset by fears of a China property crisis, rising inflation and a late interest rate surge sparked by the Federal Reserve signaling it would start removing stimulus soon.</p>\n<p>\"We wouldn't get caught up in any end-of-quarter machinations today and continue to advise fading rallies (especially in tech) as the coming weeks will stay rocky,\" wrote Adam Crisafulli of Vital Knowledge.</p>\n<p>The 10-year Treasury yield fell 3 basis points to 1.52% on Thursday (1 basis point equals 0.01%). The rate was at 1.30% to end August before surging to end this month.</p>\n<p>September’s losses have led to a middling third quarter for the market. For the 3-month period, the Dow is slightly in the red, while the Nasdaq Composite is just about flat. The S&amp;P 500 is up 1.4%. The S&amp;P 500 is still up 16% on the year.</p>\n<p>October has a reputation for some violent sell-offs but overall is typically the start of a better seasonal performance for stocks. The S&amp;P 500 averages a 0.8% gain for the month, according to the Stock Trader’s Almanac.</p>\n<p>“September lived up to its reputation and dented stock portfolio returns, but not too badly,” wrote Ed Yardeni of Yardeni Research. “There has been a lot of concern that higher wages, higher energy prices, and higher transportation costs will weigh on earnings for the remainder of this year and into 2022. It’s certainly something we’ll be tracking. But so far, analysts remain relatively sanguine.”</p>\n<p>Concerns about inflation and supply chain issues continued to hamper stocks.Shares of Bed Bath &amp; Beyond fell more than 28%&nbsp;in morning&nbsp; trading after the company said those issues hurt the company’s second quarter results, and the news also weighed on fellow retail stocks.</p>\n<p>Fed Chair Jerome Powell will testify to the House Financial Services Committee at 10 a.m. ET Thursday alongside Treasury Secretary Janet Yellen. Powell&nbsp;told a European Central Bank panel on Wednesday&nbsp;that he was frustrated by persistent inflation.</p>\n<p>“It’s also frustrating to see the bottlenecks and supply chain problems not getting better — in fact at the margins apparently getting a little bit worse,” Powell said. “We see that continuing into next year probably, and holding up inflation longer than we had thought.”</p>\n<p>On the data front,initial jobless claims&nbsp;for the prior week came in at 362,000. Economists are expecting a print of 335,000, according to Dow Jones.</p>\n<p>The Dow and S&amp;P 500 inched higher during regular trading Wednesday. The 30-stock Dow advanced about 90 points for its fifth positive session in the last six, while the S&amp;P 500 gained 0.16%, breaking a 2-day losing streak.</p>\n<p>The Nasdaq Composite, meanwhile, declined 0.24% for its fourth straight negative session. The technology sector declined again on Wednesday and is now down 4% for the week, making it the worst-performing S&amp;P group.</p>\n<p>The tech decline came as the 10-year Treasury yield hit a high of 1.56% on Wednesday, after rising to 1.567% on Tuesday. The move higher is pressuring tech stocks since it makes future cash flows look less attractive.</p>\n<p>Wells Fargo noted that pullbacks are to be expected. \"This is a normal re-pricing of risk based on a higher cost of capital and greater market uncertainty,\" the firm said Wednesday in a note to clients.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rise slightly as Wall Street tries to end losing month on a high note</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rise slightly as Wall Street tries to end losing month on a high note\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-30 21:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stocks rose slightly on Thursday as investors get to close out a volatile and losing month for stocks.</p>\n<p>The Dow Jones Industrial Average gained 107 points, or 0.3%. The S&amp;P 500 added 0.4% and Nasdaq Composite gained 0.6%.</p>\n<p>Tech stocks bounced a bit in morning trading after struggling this week because of a rapid rise in rates. The&nbsp;10-year Treasury yield&nbsp;was little changed in early trading.</p>\n<p>Chip stocks, including Nvidia and Micron, were higher after weighing on the broader market on Wednesday. Facebook and Apple saw modest gains in early trading, while Netflix jumped more than 2%.</p>\n<p>Stocks also got a boost as Senate Majority Leader Chuck Schumer said late Wednesday that the chamber had reached a deal to avoid a government shutdown this week. Schumer said&nbsp;he would schedule a vote on Thursday&nbsp;for the stopgap measure that would keep the government running into early December. The deal would still need to pass the House.</p>\n<p>For the month, the Dow is down 2.7%, the S&amp;P 500 is off by 3.6% and the Nasdaq Composite has shed 4.9%. September has lived up to its losing reputation with the market beset by fears of a China property crisis, rising inflation and a late interest rate surge sparked by the Federal Reserve signaling it would start removing stimulus soon.</p>\n<p>\"We wouldn't get caught up in any end-of-quarter machinations today and continue to advise fading rallies (especially in tech) as the coming weeks will stay rocky,\" wrote Adam Crisafulli of Vital Knowledge.</p>\n<p>The 10-year Treasury yield fell 3 basis points to 1.52% on Thursday (1 basis point equals 0.01%). The rate was at 1.30% to end August before surging to end this month.</p>\n<p>September’s losses have led to a middling third quarter for the market. For the 3-month period, the Dow is slightly in the red, while the Nasdaq Composite is just about flat. The S&amp;P 500 is up 1.4%. The S&amp;P 500 is still up 16% on the year.</p>\n<p>October has a reputation for some violent sell-offs but overall is typically the start of a better seasonal performance for stocks. The S&amp;P 500 averages a 0.8% gain for the month, according to the Stock Trader’s Almanac.</p>\n<p>“September lived up to its reputation and dented stock portfolio returns, but not too badly,” wrote Ed Yardeni of Yardeni Research. “There has been a lot of concern that higher wages, higher energy prices, and higher transportation costs will weigh on earnings for the remainder of this year and into 2022. It’s certainly something we’ll be tracking. But so far, analysts remain relatively sanguine.”</p>\n<p>Concerns about inflation and supply chain issues continued to hamper stocks.Shares of Bed Bath &amp; Beyond fell more than 28%&nbsp;in morning&nbsp; trading after the company said those issues hurt the company’s second quarter results, and the news also weighed on fellow retail stocks.</p>\n<p>Fed Chair Jerome Powell will testify to the House Financial Services Committee at 10 a.m. ET Thursday alongside Treasury Secretary Janet Yellen. Powell&nbsp;told a European Central Bank panel on Wednesday&nbsp;that he was frustrated by persistent inflation.</p>\n<p>“It’s also frustrating to see the bottlenecks and supply chain problems not getting better — in fact at the margins apparently getting a little bit worse,” Powell said. “We see that continuing into next year probably, and holding up inflation longer than we had thought.”</p>\n<p>On the data front,initial jobless claims&nbsp;for the prior week came in at 362,000. Economists are expecting a print of 335,000, according to Dow Jones.</p>\n<p>The Dow and S&amp;P 500 inched higher during regular trading Wednesday. The 30-stock Dow advanced about 90 points for its fifth positive session in the last six, while the S&amp;P 500 gained 0.16%, breaking a 2-day losing streak.</p>\n<p>The Nasdaq Composite, meanwhile, declined 0.24% for its fourth straight negative session. The technology sector declined again on Wednesday and is now down 4% for the week, making it the worst-performing S&amp;P group.</p>\n<p>The tech decline came as the 10-year Treasury yield hit a high of 1.56% on Wednesday, after rising to 1.567% on Tuesday. The move higher is pressuring tech stocks since it makes future cash flows look less attractive.</p>\n<p>Wells Fargo noted that pullbacks are to be expected. \"This is a normal re-pricing of risk based on a higher cost of capital and greater market uncertainty,\" the firm said Wednesday in a note to clients.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190243332","content_text":"U.S. stocks rose slightly on Thursday as investors get to close out a volatile and losing month for stocks.\nThe Dow Jones Industrial Average gained 107 points, or 0.3%. The S&P 500 added 0.4% and Nasdaq Composite gained 0.6%.\nTech stocks bounced a bit in morning trading after struggling this week because of a rapid rise in rates. The 10-year Treasury yield was little changed in early trading.\nChip stocks, including Nvidia and Micron, were higher after weighing on the broader market on Wednesday. Facebook and Apple saw modest gains in early trading, while Netflix jumped more than 2%.\nStocks also got a boost as Senate Majority Leader Chuck Schumer said late Wednesday that the chamber had reached a deal to avoid a government shutdown this week. Schumer said he would schedule a vote on Thursday for the stopgap measure that would keep the government running into early December. The deal would still need to pass the House.\nFor the month, the Dow is down 2.7%, the S&P 500 is off by 3.6% and the Nasdaq Composite has shed 4.9%. September has lived up to its losing reputation with the market beset by fears of a China property crisis, rising inflation and a late interest rate surge sparked by the Federal Reserve signaling it would start removing stimulus soon.\n\"We wouldn't get caught up in any end-of-quarter machinations today and continue to advise fading rallies (especially in tech) as the coming weeks will stay rocky,\" wrote Adam Crisafulli of Vital Knowledge.\nThe 10-year Treasury yield fell 3 basis points to 1.52% on Thursday (1 basis point equals 0.01%). The rate was at 1.30% to end August before surging to end this month.\nSeptember’s losses have led to a middling third quarter for the market. For the 3-month period, the Dow is slightly in the red, while the Nasdaq Composite is just about flat. The S&P 500 is up 1.4%. The S&P 500 is still up 16% on the year.\nOctober has a reputation for some violent sell-offs but overall is typically the start of a better seasonal performance for stocks. The S&P 500 averages a 0.8% gain for the month, according to the Stock Trader’s Almanac.\n“September lived up to its reputation and dented stock portfolio returns, but not too badly,” wrote Ed Yardeni of Yardeni Research. “There has been a lot of concern that higher wages, higher energy prices, and higher transportation costs will weigh on earnings for the remainder of this year and into 2022. It’s certainly something we’ll be tracking. But so far, analysts remain relatively sanguine.”\nConcerns about inflation and supply chain issues continued to hamper stocks.Shares of Bed Bath & Beyond fell more than 28% in morning  trading after the company said those issues hurt the company’s second quarter results, and the news also weighed on fellow retail stocks.\nFed Chair Jerome Powell will testify to the House Financial Services Committee at 10 a.m. ET Thursday alongside Treasury Secretary Janet Yellen. Powell told a European Central Bank panel on Wednesday that he was frustrated by persistent inflation.\n“It’s also frustrating to see the bottlenecks and supply chain problems not getting better — in fact at the margins apparently getting a little bit worse,” Powell said. “We see that continuing into next year probably, and holding up inflation longer than we had thought.”\nOn the data front,initial jobless claims for the prior week came in at 362,000. Economists are expecting a print of 335,000, according to Dow Jones.\nThe Dow and S&P 500 inched higher during regular trading Wednesday. The 30-stock Dow advanced about 90 points for its fifth positive session in the last six, while the S&P 500 gained 0.16%, breaking a 2-day losing streak.\nThe Nasdaq Composite, meanwhile, declined 0.24% for its fourth straight negative session. The technology sector declined again on Wednesday and is now down 4% for the week, making it the worst-performing S&P group.\nThe tech decline came as the 10-year Treasury yield hit a high of 1.56% on Wednesday, after rising to 1.567% on Tuesday. The move higher is pressuring tech stocks since it makes future cash flows look less attractive.\nWells Fargo noted that pullbacks are to be expected. \"This is a normal re-pricing of risk based on a higher cost of capital and greater market uncertainty,\" the firm said Wednesday in a note to clients.","news_type":1},"isVote":1,"tweetType":1,"viewCount":43,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698098030,"gmtCreate":1640255617815,"gmtModify":1640255620311,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698098030","repostId":"2193422197","repostType":4,"repost":{"id":"2193422197","pubTimestamp":1640252880,"share":"https://www.laohu8.com/m/news/2193422197?lang=&edition=full","pubTime":"2021-12-23 17:48","market":"us","language":"en","title":"If I Could Only Buy 1 Stock Right Now, This Would Be It","url":"https://stock-news.laohu8.com/highlight/detail?id=2193422197","media":"Motley Fool","summary":"Costco offers solid growth and the prospect of special dividends.","content":"<p>A diversified portfolio helps spread out your risk. That's because you have other stocks to pick up the slack in case <a href=\"https://laohu8.com/S/AONE.U\">one</a> company runs into trouble. However, it's OK to have a favorite. Hence, if you could only buy one stock, it should be the best of the lot.</p>\n<p><b>Costco Wholesale </b>(NASDAQ:COST) has been around for decades, but this isn't a mature, slow-growing company. Let's take a closer look to see what makes Costco so special.</p>\n<h2>A fine business</h2>\n<p>Costco operates large warehouses with a wide variety of goods and services at low prices to its members, who pay a fee to join. In the U.S. and Canada, the basic annual charge is $60. Executive members pay double that amount, but receive a 2% reward on their purchases that they can redeem at the warehouses.</p>\n<p>Members clearly find it worthwhile. Renewal rates have hovered around 90% for years. And Costco keeps adding new members. The number of paid memberships has grown steadily, reaching 61.7 million at the end of the latest fiscal year (ended Aug. 29), up from 53.9 million only a couple of years ago.</p>\n<p>Its loyal members continue to spend as demonstrated by years of same-store sales (comps) growth. In the first quarter, comps -- excluding changes in gasoline prices and foreign currency -- were up 9.8%. That follows a 13.4% gain last year. What's more, the growth has been accelerating. In 2017, comps increased just 4%.</p>\n<p>The company's profitability has been growing at a nice clip too. Operating income in the latest fiscal year totaled $6.7 billion, 63% higher than five years ago. And it continues to improve. Thanks to strong execution in the first quarter, operating income grew by more than 18% to $1.7 billion -- and that's despite dealing with supply chain issues and higher costs plaguing the retail industry.</p>\n<h2>Nice growth outlook</h2>\n<p>This year's capital expenditure budget is over $4 billion, about an 11% increase from last year. Management is spending this mostly on logistics, e-commerce fulfillment operations, and expanding warehouses.</p>\n<p>As of August, Costco had 815 warehouses, an increase of 100 from August 2016. And the company continues to add more, including another eight stores already in the first quarter and 19 more on the way in the next three quarters.</p>\n<p>With stores continuing to do well and e-commerce sales growing rapidly (up 13.3% in the most recent quarter), this should all help Costco's top line growth.</p>\n<h2>Dividends with a kick</h2>\n<p>Costco has raised its dividend annually since initiating it in 2004 and there's every reason to think it will continue to do so. In May, the company increased its quarterly payout by 13% to $0.79 per share. The dividend yield currently stands at a modest 0.6% -- less than half of the <b>S&amp;P 500</b>'s 1.3%.</p>\n<p>However, Costco has made a habit out of declaring large, special dividends every few years. A year ago, it paid out $10 per share and in May 2017 it gave $7. While there's no guarantee it will do so in the future, Costco's increased profitability means it's a good bet that the company will continue this practice.</p>\n<p>Costco has proven it can offer a great value proposition to customers, and its sales and earnings growth don't look likely to stop anytime soon. Meanwhile, the company also provides improving dividends, which it supplements with special payments. It's this combination of growth and dividends that puts Costco at the top of my list of stocks.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>If I Could Only Buy 1 Stock Right Now, This Would Be It</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIf I Could Only Buy 1 Stock Right Now, This Would Be It\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 17:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/22/if-i-could-only-buy-1-stock-right-now-this-would-b/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A diversified portfolio helps spread out your risk. That's because you have other stocks to pick up the slack in case one company runs into trouble. However, it's OK to have a favorite. Hence, if you ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/22/if-i-could-only-buy-1-stock-right-now-this-would-b/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4550":"红杉资本持仓","COST":"好市多","BK4155":"大卖场与超市","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4504":"桥水持仓"},"source_url":"https://www.fool.com/investing/2021/12/22/if-i-could-only-buy-1-stock-right-now-this-would-b/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193422197","content_text":"A diversified portfolio helps spread out your risk. That's because you have other stocks to pick up the slack in case one company runs into trouble. However, it's OK to have a favorite. Hence, if you could only buy one stock, it should be the best of the lot.\nCostco Wholesale (NASDAQ:COST) has been around for decades, but this isn't a mature, slow-growing company. Let's take a closer look to see what makes Costco so special.\nA fine business\nCostco operates large warehouses with a wide variety of goods and services at low prices to its members, who pay a fee to join. In the U.S. and Canada, the basic annual charge is $60. Executive members pay double that amount, but receive a 2% reward on their purchases that they can redeem at the warehouses.\nMembers clearly find it worthwhile. Renewal rates have hovered around 90% for years. And Costco keeps adding new members. The number of paid memberships has grown steadily, reaching 61.7 million at the end of the latest fiscal year (ended Aug. 29), up from 53.9 million only a couple of years ago.\nIts loyal members continue to spend as demonstrated by years of same-store sales (comps) growth. In the first quarter, comps -- excluding changes in gasoline prices and foreign currency -- were up 9.8%. That follows a 13.4% gain last year. What's more, the growth has been accelerating. In 2017, comps increased just 4%.\nThe company's profitability has been growing at a nice clip too. Operating income in the latest fiscal year totaled $6.7 billion, 63% higher than five years ago. And it continues to improve. Thanks to strong execution in the first quarter, operating income grew by more than 18% to $1.7 billion -- and that's despite dealing with supply chain issues and higher costs plaguing the retail industry.\nNice growth outlook\nThis year's capital expenditure budget is over $4 billion, about an 11% increase from last year. Management is spending this mostly on logistics, e-commerce fulfillment operations, and expanding warehouses.\nAs of August, Costco had 815 warehouses, an increase of 100 from August 2016. And the company continues to add more, including another eight stores already in the first quarter and 19 more on the way in the next three quarters.\nWith stores continuing to do well and e-commerce sales growing rapidly (up 13.3% in the most recent quarter), this should all help Costco's top line growth.\nDividends with a kick\nCostco has raised its dividend annually since initiating it in 2004 and there's every reason to think it will continue to do so. In May, the company increased its quarterly payout by 13% to $0.79 per share. The dividend yield currently stands at a modest 0.6% -- less than half of the S&P 500's 1.3%.\nHowever, Costco has made a habit out of declaring large, special dividends every few years. A year ago, it paid out $10 per share and in May 2017 it gave $7. While there's no guarantee it will do so in the future, Costco's increased profitability means it's a good bet that the company will continue this practice.\nCostco has proven it can offer a great value proposition to customers, and its sales and earnings growth don't look likely to stop anytime soon. Meanwhile, the company also provides improving dividends, which it supplements with special payments. It's this combination of growth and dividends that puts Costco at the top of my list of stocks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":304,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690099398,"gmtCreate":1639611577289,"gmtModify":1639611579710,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"L","listText":"L","text":"L","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690099398","repostId":"1117099747","repostType":4,"repost":{"id":"1117099747","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639610664,"share":"https://www.laohu8.com/m/news/1117099747?lang=&edition=full","pubTime":"2021-12-16 07:24","market":"us","language":"en","title":"Bad Omen For Tesla? Here's What Happened To Amazon Stock After Jeff Bezos Was Time's 'Person Of The Year'","url":"https://stock-news.laohu8.com/highlight/detail?id=1117099747","media":"Benzinga","summary":"Controversial and influential Tesla Inc CEO Elon Muskwas recently named Time Magazine’s \"Person of t","content":"<p>Controversial and influential&nbsp;<b>Tesla Inc</b>&nbsp;<b>CEO Elon Musk</b>was recently named&nbsp;<b>Time Magazine’s \"Person of the Year\" for 2021</b>. The award is a tremendous honor for Musk, but some long-time&nbsp;<b>Amazon.com, Inc.</b>&nbsp;investors may still have nightmares about the time Amazon founder and former CEO&nbsp;<b>Jeff Bezos</b>&nbsp;was also named Time’s \"Person of the Year.\"</p>\n<p><b>Time Magazine Curse?</b>Bezos received \"Person of the Year\" honors for 1999 on Dec. 20, 1999. On that day, Amazon shares closed at $97. Less than two years later, Amazon shares closed at a new all-time low of $5.67 on Sept. 27, 2001.<b>During that 11-month stretch immediately following Bezos’ award, Amazon shares lost an incredible 94% of their value.</b></p>\n<p>Bezos and Musk have had a somewhat contentious rivalry over the years. Musk and Bezos are also currently the two most wealthy people in the world, worth a combined $437 billion.</p>\n<p>Tesla investors are hoping Tesla shares can avoid the same Time Magazine curse that hit Amazon stock back in 1999. So far, they have not. Musk was announced as \"Person of the Year\" on Monday, and Tesla shares are now down 7.6% since last Friday’s close.</p>\n<p><b>Tesla Risk:</b>Former hedge fund manager Whitney Tilson said Wednesday&nbsp;he does not expect Tesla to repeat Amazon’s 94% Time Magazine sell-off, and he would not recommend traders short Tesla stock.</p>\n<p>“But I will say this: as I scan the 100 companies with the largest market caps that trade in the U.S., Tesla jumps out at me as the one that could cost investors the most money, the fastest…” Tilson said.</p>\n<p><b>Benzinga’s Take:</b>The silver lining for Amazon investors that held on through the bursting of the dot-com bubble is Amazon’s stock has been a more than 600-bagger since it bottomed in 2001. In addition, the stocks of&nbsp;other billionaire tech CEOs have fared much better following \"Person of the Year\" honors. In the two years after Bill Gates was named Time \"Person of the Year\" in 2005,<b>Microsoft Corporation</b>&nbsp;stock was up 31.3%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bad Omen For Tesla? Here's What Happened To Amazon Stock After Jeff Bezos Was Time's 'Person Of The Year'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBad Omen For Tesla? Here's What Happened To Amazon Stock After Jeff Bezos Was Time's 'Person Of The Year'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-16 07:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Controversial and influential&nbsp;<b>Tesla Inc</b>&nbsp;<b>CEO Elon Musk</b>was recently named&nbsp;<b>Time Magazine’s \"Person of the Year\" for 2021</b>. The award is a tremendous honor for Musk, but some long-time&nbsp;<b>Amazon.com, Inc.</b>&nbsp;investors may still have nightmares about the time Amazon founder and former CEO&nbsp;<b>Jeff Bezos</b>&nbsp;was also named Time’s \"Person of the Year.\"</p>\n<p><b>Time Magazine Curse?</b>Bezos received \"Person of the Year\" honors for 1999 on Dec. 20, 1999. On that day, Amazon shares closed at $97. Less than two years later, Amazon shares closed at a new all-time low of $5.67 on Sept. 27, 2001.<b>During that 11-month stretch immediately following Bezos’ award, Amazon shares lost an incredible 94% of their value.</b></p>\n<p>Bezos and Musk have had a somewhat contentious rivalry over the years. Musk and Bezos are also currently the two most wealthy people in the world, worth a combined $437 billion.</p>\n<p>Tesla investors are hoping Tesla shares can avoid the same Time Magazine curse that hit Amazon stock back in 1999. So far, they have not. Musk was announced as \"Person of the Year\" on Monday, and Tesla shares are now down 7.6% since last Friday’s close.</p>\n<p><b>Tesla Risk:</b>Former hedge fund manager Whitney Tilson said Wednesday&nbsp;he does not expect Tesla to repeat Amazon’s 94% Time Magazine sell-off, and he would not recommend traders short Tesla stock.</p>\n<p>“But I will say this: as I scan the 100 companies with the largest market caps that trade in the U.S., Tesla jumps out at me as the one that could cost investors the most money, the fastest…” Tilson said.</p>\n<p><b>Benzinga’s Take:</b>The silver lining for Amazon investors that held on through the bursting of the dot-com bubble is Amazon’s stock has been a more than 600-bagger since it bottomed in 2001. In addition, the stocks of&nbsp;other billionaire tech CEOs have fared much better following \"Person of the Year\" honors. In the two years after Bill Gates was named Time \"Person of the Year\" in 2005,<b>Microsoft Corporation</b>&nbsp;stock was up 31.3%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117099747","content_text":"Controversial and influential Tesla Inc CEO Elon Muskwas recently named Time Magazine’s \"Person of the Year\" for 2021. The award is a tremendous honor for Musk, but some long-time Amazon.com, Inc. investors may still have nightmares about the time Amazon founder and former CEO Jeff Bezos was also named Time’s \"Person of the Year.\"\nTime Magazine Curse?Bezos received \"Person of the Year\" honors for 1999 on Dec. 20, 1999. On that day, Amazon shares closed at $97. Less than two years later, Amazon shares closed at a new all-time low of $5.67 on Sept. 27, 2001.During that 11-month stretch immediately following Bezos’ award, Amazon shares lost an incredible 94% of their value.\nBezos and Musk have had a somewhat contentious rivalry over the years. Musk and Bezos are also currently the two most wealthy people in the world, worth a combined $437 billion.\nTesla investors are hoping Tesla shares can avoid the same Time Magazine curse that hit Amazon stock back in 1999. So far, they have not. Musk was announced as \"Person of the Year\" on Monday, and Tesla shares are now down 7.6% since last Friday’s close.\nTesla Risk:Former hedge fund manager Whitney Tilson said Wednesday he does not expect Tesla to repeat Amazon’s 94% Time Magazine sell-off, and he would not recommend traders short Tesla stock.\n“But I will say this: as I scan the 100 companies with the largest market caps that trade in the U.S., Tesla jumps out at me as the one that could cost investors the most money, the fastest…” Tilson said.\nBenzinga’s Take:The silver lining for Amazon investors that held on through the bursting of the dot-com bubble is Amazon’s stock has been a more than 600-bagger since it bottomed in 2001. In addition, the stocks of other billionaire tech CEOs have fared much better following \"Person of the Year\" honors. In the two years after Bill Gates was named Time \"Person of the Year\" in 2005,Microsoft Corporation stock was up 31.3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879721212,"gmtCreate":1636775745746,"gmtModify":1636775746677,"author":{"id":"3578711428062414","authorId":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Li","listText":"Li","text":"Li","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/879721212","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p>\n<p>“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p>\n<p>Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p>\n<p>Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p>\n<p>In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p>\n<p>The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p>\n<p>Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p>\n<p>The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p>\n<p>The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p>\n<p>The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p>\n<p>While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p>\n<p>In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p>\n<p>The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p>\n<p>“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p>\n<p>Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p>\n<p>“[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p>\n<p>The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p>\n<p>“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p>\n<p>Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p>\n<p>“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p>\n<p>Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p>\n<p>“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p>\n<p>That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p>\n<p>Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p>\n<p>Moderna shares are down more than 40% over the past three months.</p>\n<p>As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p>\n<p>When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p>\n<p>That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p>\n<p>Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p>\n<p>Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p>\n<p>An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that...</p>\n\n<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":13,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}